[go: up one dir, main page]

JP2017218381A - Thiophene ring-condensed aromatic compound and manufacturing method therefor - Google Patents

Thiophene ring-condensed aromatic compound and manufacturing method therefor Download PDF

Info

Publication number
JP2017218381A
JP2017218381A JP2016111317A JP2016111317A JP2017218381A JP 2017218381 A JP2017218381 A JP 2017218381A JP 2016111317 A JP2016111317 A JP 2016111317A JP 2016111317 A JP2016111317 A JP 2016111317A JP 2017218381 A JP2017218381 A JP 2017218381A
Authority
JP
Japan
Prior art keywords
ring
compound
group
polycyclic aromatic
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016111317A
Other languages
Japanese (ja)
Inventor
健一郎 伊丹
Kenichiro Itami
健一郎 伊丹
泰知 瀬川
Yasutomo Segawa
泰知 瀬川
リンクイ メン
Lin Qui Meng
リンクイ メン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagoya University NUC
Original Assignee
Nagoya University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagoya University NUC filed Critical Nagoya University NUC
Priority to JP2016111317A priority Critical patent/JP2017218381A/en
Publication of JP2017218381A publication Critical patent/JP2017218381A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method capable of condensing a thiophene ring on various aromatic compounds only with simple one process.SOLUTION: There is provided a manufacturing method of a thiophene ring-condensed aromatic compound having one or more thiophene ring condensed to a polycyclic aromatic hydrocarbon ring or heterocyclic aromatic ring, including a process of reacting a polycyclic aromatic compound or a heterocyclic compound with sulfur and the polycyclic aromatic compound or the heterocyclic compound has one or more structure represented by the general formula (1), where Rrepresents an aryl group which may be substituted, n represents an integer of 1 to more and binds represented by dotted lines and broken lines represent single bonds or double bonds.SELECTED DRAWING: None

Description

本発明は、チオフェン環縮合芳香族化合物及びその製造方法に関する。   The present invention relates to a thiophene ring-fused aromatic compound and a method for producing the same.

チオフェンが縮環したπ共役芳香族化合物は、有機半導体材料として、有機EL、トランジスタ、太陽電池、導電材料、感光体、液晶材料等、様々な分野で用いられている。   Π-conjugated aromatic compounds fused with thiophene are used as organic semiconductor materials in various fields such as organic EL, transistors, solar cells, conductive materials, photoconductors, and liquid crystal materials.

これまでに非常に多くのチオフェン縮環反応が報告されているが、従来のチオフェン環縮合芳香族化合物の合成には、2つの置換基を導入した多環芳香族炭化水素(PAH)にチオフェンを縮環する手法が用いられており、様々なチオフェン環縮合芳香族化合物を得る方法が報告されている(例えば、非特許文献1参照)。また、最近では、アルキニル基を有するPAHと、チオウレア、硫化ナトリウム等の硫黄源から、一段階でチオフェン環縮合芳香族化合物を得る方法も知られている(例えば、非特許文献2参照)。   So far, a large number of thiophene ring-condensation reactions have been reported, but for the synthesis of conventional thiophene ring-fused aromatic compounds, thiophene was added to polycyclic aromatic hydrocarbons (PAH) into which two substituents were introduced. Methods for condensing rings have been used, and methods for obtaining various thiophene ring-fused aromatic compounds have been reported (see, for example, Non-Patent Document 1). Recently, a method of obtaining a thiophene ring condensed aromatic compound in one step from PAH having an alkynyl group and a sulfur source such as thiourea and sodium sulfide is also known (see, for example, Non-Patent Document 2).

Eur. J. Org. Chem., 2013, 217-227.Eur. J. Org. Chem., 2013, 217-227. J. Am. Chem. Soc., 2013, 135, 11445-11448.J. Am. Chem. Soc., 2013, 135, 11445-11448.

しかしながら、非特許文献1に記載の方法では、PAHに2つの置換基を導入した基質が必要となるため、チオフェン環縮合芳香族化合物を合成するには多段階の反応と精製を行う煩雑な操作が必要であった。また、用いることのできる基質が制限される等、汎用性の面でも課題がある。また、非特許文献2に記載の方法では、適切な位置にカルボニル基を有する基質しか使用することができず、汎用性の面で課題がある。   However, since the method described in Non-Patent Document 1 requires a substrate in which two substituents are introduced into PAH, a complicated operation involving multi-step reaction and purification is required to synthesize a thiophene-ring condensed aromatic compound. Was necessary. In addition, there are problems in terms of versatility, such as limitations on the substrates that can be used. In the method described in Non-Patent Document 2, only a substrate having a carbonyl group at an appropriate position can be used, and there is a problem in versatility.

優れた新規有機半導体材料の開発を目指し、チオフェン環縮合芳香族化合物の探索を効率的に行うためには、より簡便な手法で、様々な基質に対してチオフェン環を縮環することができる方法の開発が急務である。そこで、本発明は、様々な芳香族化合物に対して、チオフェン環を簡便且つ1工程のみで縮環することができる方法を提供することを目的とする。   In order to efficiently search for thiophene ring-fused aromatic compounds with the aim of developing excellent new organic semiconductor materials, a method that allows thiophene rings to be fused to various substrates with a simpler method The development of is urgent. Therefore, an object of the present invention is to provide a method capable of simply condensing a thiophene ring with a single step for various aromatic compounds.

上記の課題に鑑み鋭意研究を重ねた結果、本発明者らは、特定の置換基を1つだけ導入した多環芳香族炭化水素又は複素環式化合物と、硫黄とを反応させるという非常に簡便な手法を採用することにより、1工程のみで多環芳香族炭化水素又は複素環式化合物にチオフェン環を縮環することができることを見出した。本発明は、このような知見に基づき、さらに研究を重ねた結果、完成されたものである。すなわち、本発明は、以下の構成を包含する。   As a result of intensive studies in view of the above problems, the present inventors have achieved a very simple reaction of reacting sulfur with a polycyclic aromatic hydrocarbon or heterocyclic compound into which only one specific substituent has been introduced. By adopting such a technique, it has been found that a thiophene ring can be condensed to a polycyclic aromatic hydrocarbon or heterocyclic compound in only one step. The present invention has been completed as a result of further research based on such knowledge. That is, the present invention includes the following configurations.

項1.多環芳香族炭化水素環又は複素芳香環に、1個以上のチオフェン環が縮合したチオフェン環縮合芳香族化合物の製造方法であって、
多環芳香族化合物又は複素環式化合物と、硫黄とを反応させる工程を備え、
前記多環芳香族化合物又は複素環式化合物は、一般式(1):
Item 1. A method for producing a thiophene ring condensed aromatic compound in which one or more thiophene rings are condensed to a polycyclic aromatic hydrocarbon ring or a heteroaromatic ring,
Comprising a step of reacting a polycyclic aromatic compound or heterocyclic compound with sulfur;
The polycyclic aromatic compound or heterocyclic compound has the general formula (1):

Figure 2017218381
Figure 2017218381

[式中、R1は置換されていてもよいアリール基を示す。nは1以上の整数を示す。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される構造を1個以上有している、製造方法。
[Wherein, R 1 represents an optionally substituted aryl group. n represents an integer of 1 or more. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
A manufacturing method having one or more structures represented by:

項2.前記多環芳香族化合物又は複素環式化合物が、一般式(3):   Item 2. The polycyclic aromatic compound or heterocyclic compound is represented by the general formula (3):

Figure 2017218381
Figure 2017218381

[式中、R1及びnは前記に同じである。Arは置換されていてもよい多環芳香族炭化水素環又は置換されていてもよい複素芳香環を示す。R3は−(C≡C)n−R1で表される基を示す。R3が結合しているAr環上の炭素原子と隣接している炭素原子の少なくとも1つの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合している。mは0以上の整数を示す。]
で表される化合物である、項1に記載の製造方法。
[Wherein, R 1 and n are the same as defined above. Ar represents a polycyclic aromatic hydrocarbon ring which may be substituted or a heteroaromatic ring which may be substituted. R 3 represents a group represented by — (C≡C) n —R 1 . The group represented by-(C≡C) n -R 1 is not bonded to at least one carbon atom adjacent to the carbon atom on the Ar ring to which R 3 is bonded. Hydrogen atoms are bonded. m represents an integer of 0 or more. ]
Item 2. The production method according to Item 1, which is a compound represented by:

項3.前記Arが、置換基を有していてもよいナフタレン環、置換基を有していてもよいアントラセン環、置換基を有していてもよいフェナントレン環、置換基を有していてもよいテトラセン環、置換基を有していてもよいピレン環、置換基を有していてもよいフルオランテン環、置換基を有していてもよいペンタセン環、置換基を有していてもよいペリレン環、置換基を有していてもよいコラニュレン環、置換基を有していてもよいクリセン環、置換基を有していてもよいチオフェン環、置換基を有していてもよいベンゾチオフェン環、若しくは置換基を有していてもよいジチエノベンゼン環、又はこれらの環にベンゼン環を1個以上縮合した環である、項2に記載の製造方法。   Item 3. Ar represents an optionally substituted naphthalene ring, an optionally substituted anthracene ring, an optionally substituted phenanthrene ring, and an optionally substituted tetracene. A ring, an optionally substituted pyrene ring, an optionally substituted fluoranthene ring, an optionally substituted pentacene ring, an optionally substituted perylene ring, A corannulene ring optionally having a substituent, a chrysene ring optionally having a substituent, a thiophene ring optionally having a substituent, a benzothiophene ring optionally having a substituent, or Item 3. The production method according to Item 2, which is a dithienobenzene ring optionally having a substituent, or a ring obtained by condensing one or more benzene rings to these rings.

項4.前記反応工程が、極性溶媒中で行われる、項1〜3のいずれかに記載の製造方法。   Item 4. Item 4. The production method according to any one of Items 1 to 3, wherein the reaction step is performed in a polar solvent.

項5.前記多環芳香族化合物又は複素環式化合物が、一般式(1A)   Item 5. The polycyclic aromatic compound or heterocyclic compound has the general formula (1A)

Figure 2017218381
Figure 2017218381

[式中、R1は前記に同じである。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有しており、
製造されるチオフェン環縮合芳香族化合物が、一般式(2A):
[Wherein, R 1 is the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
Having one or more structures represented by
The produced thiophene ring-fused aromatic compound has the general formula (2A):

Figure 2017218381
Figure 2017218381

[式中、R2は、R1と同一の基か、R1が還元された基であり、置換されていてもよいアリール基を示す。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有している、項1に記載の製造方法。
Wherein, R 2 is either same group as R 1, a group R 1 is reduced, it represents an aryl group which may be substituted. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
Item 2. The production method according to Item 1, comprising one or more structures represented by:

項6.前記多環芳香族化合物又は複素環式化合物が、一般式(1B)   Item 6. The polycyclic aromatic compound or heterocyclic compound has the general formula (1B)

Figure 2017218381
Figure 2017218381

[式中、R1は前記に同じである。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有しており、
製造されるチオフェン環縮合芳香族化合物が、一般式(2B):
[Wherein, R 1 is the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
Having one or more structures represented by
The produced thiophene ring-fused aromatic compound has the general formula (2B):

Figure 2017218381
Figure 2017218381

[式中、R2は、R1と同一の基か、R1が還元された基であり、置換されていてもよいアリール基を示す。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有している、項1に記載の製造方法。
Wherein, R 2 is either same group as R 1, a group R 1 is reduced, it represents an aryl group which may be substituted. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
Item 2. The production method according to Item 1, comprising one or more structures represented by:

項7.前記多環芳香族化合物又は複素環式化合物が、一般式(3E):   Item 7. The polycyclic aromatic compound or the heterocyclic compound is represented by the general formula (3E):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。]
で表される化合物、又は一般式(3F):
[Wherein, R 1 is the same or different and is the same as defined above. ]
Or a compound represented by the general formula (3F):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。]
で表される化合物である、項1〜6のいずれかに記載の製造方法
[Wherein, R 1 is the same or different and is the same as defined above. ]
The manufacturing method in any one of claim | item 1 -6 which is a compound represented by these.

項8.置換基を有していてもよい多環芳香族炭化水素環に、1個以上の置換基を有していてもよいチオフェン環が縮合したチオフェン環縮合芳香族化合物であって、
多環芳香族化合物と、硫黄とを反応させてなり、
前記多環芳香族化合物は、
一般式(3):
Item 8. A thiophene ring-fused aromatic compound in which a polycyclic aromatic hydrocarbon ring which may have a substituent is condensed with a thiophene ring which may have one or more substituents,
A reaction between a polycyclic aromatic compound and sulfur,
The polycyclic aromatic compound is
General formula (3):

Figure 2017218381
Figure 2017218381

[式中、R1は置換されていてもよいアリール基を示す。nは1以上の整数を示す。Arは置換されていてもよい多環芳香族炭化水素環又は置換されていてもよい複素芳香環を示す。R3は−(C≡C)n−R1で表される基を示す。R3が結合しているAr環上の炭素原子と隣接している炭素原子の少なくとも1つの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合している。mは0以上の整数を示す。]
で表される、チオフェン環縮合芳香族化合物(ただし、ナフタレン環に置換基を有していてもよいチオフェン環が2個縮合した化合物、アントラセン環に置換基を有していてもよいチオフェン環が1個又は4個縮合した化合物、及びアントラキノンに置換基を有していてもよいチオフェン環が1個縮合した化合物を除く)。
[Wherein, R 1 represents an optionally substituted aryl group. n represents an integer of 1 or more. Ar represents a polycyclic aromatic hydrocarbon ring which may be substituted or a heteroaromatic ring which may be substituted. R 3 represents a group represented by — (C≡C) n —R 1 . The group represented by-(C≡C) n -R 1 is not bonded to at least one carbon atom adjacent to the carbon atom on the Ar ring to which R 3 is bonded. Hydrogen atoms are bonded. m represents an integer of 0 or more. ]
A thiophene ring-condensed aromatic compound represented by (a compound in which two thiophene rings optionally having a substituent are condensed on the naphthalene ring, a thiophene ring optionally having a substituent on the anthracene ring is 1 or 4 condensed compounds, and compounds in which anthraquinone optionally having one substituent thiophene ring is condensed).

本発明によれば、特定の置換基を1つだけ導入した多環芳香族炭化水素又は複素環式化合物と、硫黄とを反応させるという非常に簡便な手法を採用することにより、1工程のみで多環芳香族炭化水素又は複素環式化合物にチオフェン環を縮環することができる。このため、2つの置換基を導入した基質を準備する必要がないため、従来と比較してより簡便な方法である。   According to the present invention, by adopting a very simple technique of reacting a polycyclic aromatic hydrocarbon or heterocyclic compound into which only one specific substituent is introduced, and sulfur, it is possible to perform the process only in one step. A thiophene ring can be fused to a polycyclic aromatic hydrocarbon or heterocyclic compound. For this reason, it is not necessary to prepare a substrate into which two substituents are introduced, which is a simpler method than in the past.

実施例1−1で得た化合物2aの吸収スペクトル及び蛍光スペクトルである。2 is an absorption spectrum and a fluorescence spectrum of Compound 2a obtained in Example 1-1. 実施例1−2で得た化合物2fの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2f obtained in Example 1-2. 実施例1−2で得た化合物2gの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2g obtained in Example 1-2. 実施例1−2で得た化合物2hの吸収スペクトル及び蛍光スペクトルである。2 is an absorption spectrum and a fluorescence spectrum of Compound 2h obtained in Example 1-2. 実施例1−2で得た化合物2iの吸収スペクトル及び蛍光スペクトルである。2 is an absorption spectrum and a fluorescence spectrum of Compound 2i obtained in Example 1-2. 実施例1−2で得た化合物2jの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2j obtained in Example 1-2. 実施例1−2で得た化合物2kの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2k obtained in Example 1-2. 実施例1−2で得た化合物2lの吸収スペクトル及び蛍光スペクトルである。It is an absorption spectrum and a fluorescence spectrum of the compound 2l obtained in Example 1-2. 実施例1−2で得た化合物2mの吸収スペクトル及び蛍光スペクトルである。2 is an absorption spectrum and a fluorescence spectrum of the compound 2m obtained in Example 1-2. 実施例1−2で得た化合物2nの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2n obtained in Example 1-2. 実施例1−2で得た化合物2oの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2o obtained in Example 1-2. 実施例1−2で得た化合物2pの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2p obtained in Example 1-2. 実施例1−2で得た化合物2qの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2q obtained in Example 1-2. 実施例1−2で得た化合物2rの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2r obtained in Example 1-2. 実施例3−1で得た化合物2uの吸収スペクトル及び蛍光スペクトルである。2 is an absorption spectrum and a fluorescence spectrum of Compound 2u obtained in Example 3-1. 実施例3−2で得た化合物2vの吸収スペクトル及び蛍光スペクトルである。It is the absorption spectrum and fluorescence spectrum of the compound 2v obtained in Example 3-2.

1.チオフェン環縮合芳香族化合物の製造方法
本発明の製造方法は、多環芳香族炭化水素環又は複素芳香環に、1個以上のチオフェン環が縮合したチオフェン環縮合芳香族化合物の製造方法であって、
多環芳香族化合物又は複素環式化合物と、硫黄とを反応させる工程を備え、
前記多環芳香族化合物又は複素環式化合物は、一般式(1):
1. Production method of thiophene ring condensed aromatic compound The production method of the present invention is a method of producing a thiophene ring condensed aromatic compound in which one or more thiophene rings are condensed to a polycyclic aromatic hydrocarbon ring or a heteroaromatic ring. ,
Comprising a step of reacting a polycyclic aromatic compound or heterocyclic compound with sulfur;
The polycyclic aromatic compound or heterocyclic compound has the general formula (1):

Figure 2017218381
Figure 2017218381

[式中、R1は置換されていてもよいアリール基を示す。nは1以上の整数を示す。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される構造を1個以上有している。
[Wherein, R 1 represents an optionally substituted aryl group. n represents an integer of 1 or more. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
It has one or more structures represented by

このような方法を採用することにより、エチニレン基と隣接するオルト位のC−H結合の切断を伴うチオフェン縮環反応が進行する。また、前記多環芳香族化合物又は複素環式化合物が、−(C≡C)n−R1で表される基を複数有している場合には、有している数だけチオフェン環を縮環させることができる。なお、縮環反応によってチオフェン環が縮合した場合、通常、縮環したチオフェン環に、R1基がそのまま結合した芳香族化合物が得られるが、R1がニトロ基(−NO2)を有する場合には、縮環反応と同時にニトロ基が還元されてアミノ基(−NH2)となる。このため、R1がニトロ基で置換されたアリール基である場合は、縮環反応と同時にニトロ基が還元されてアミノ基で置換されたアリール基となる。 By adopting such a method, a thiophene ring condensation reaction involving cleavage of the C—H bond at the ortho position adjacent to the ethynylene group proceeds. In addition, when the polycyclic aromatic compound or heterocyclic compound has a plurality of groups represented by-(C≡C) n -R 1 , the thiophene ring is condensed by the number of the groups. Can be ringed. When a thiophene ring is condensed by a condensation reaction, an aromatic compound in which the R 1 group is directly bonded to the condensed thiophene ring is obtained, but when R 1 has a nitro group (—NO 2 ) In this case, the nitro group is reduced to the amino group (—NH 2 ) simultaneously with the ring condensation reaction. For this reason, when R 1 is an aryl group substituted with a nitro group, the nitro group is reduced simultaneously with the ring condensation reaction to become an aryl group substituted with an amino group.

さらに、より具体的には、一般式(1)で表される構造として、n= 1である場合、つまり、一般式(1A):   More specifically, when the structure represented by the general formula (1) is n = 1, that is, the general formula (1A):

Figure 2017218381
Figure 2017218381

[式中、R1は前記に同じである。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有している場合には、アリールエチニル基のオルト位のC−H結合の切断を伴うチオフェン縮環反応が進行し、一般式(2A):
[Wherein, R 1 is the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
In the case of having one or more structures represented by general formula (2A), a thiophene ring condensation reaction involving cleavage of the C—H bond at the ortho position of the arylethynyl group proceeds.

Figure 2017218381
Figure 2017218381

[式中、R2は、R1と同一の基か、R1が還元された基であり、置換されていてもよいアリール基を示す。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有するチオフェン環縮合芳香族化合物が得られる。
Wherein, R 2 is either same group as R 1, a group R 1 is reduced, it represents an aryl group which may be substituted. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
A thiophene ring-fused aromatic compound having one or more structures represented by

一方、一般式(1)で表される構造として、n= 2である場合、つまり、一般式(1B):   On the other hand, when the structure represented by the general formula (1) is n = 2, that is, the general formula (1B):

Figure 2017218381
Figure 2017218381

[式中、R1は前記に同じである。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有している場合には、アリールエチニル基のオルト位のC−H結合の切断を伴うチオフェン縮環反応が2回進行し、一般式(2B):
[Wherein, R 1 is the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
In the case of having one or more structures represented by formula (2B), the thiophene ring condensation reaction involving cleavage of the C—H bond at the ortho position of the arylethynyl group proceeds twice.

Figure 2017218381
Figure 2017218381

[式中、R2は、R1と同一の基か、R1が還元された基であり、置換されていてもよいアリール基を示す。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有するチオフェン環縮合芳香族化合物が得られる。
Wherein, R 2 is either same group as R 1, a group R 1 is reduced, it represents an aryl group which may be substituted. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
A thiophene ring-fused aromatic compound having one or more structures represented by

つまり、本発明の製造方法においては、三重結合の数だけアリールエチニル基のオルト位のC−H結合の切断を伴うチオフェン縮環反応が進行し、その回数分のチオフェン環が縮環した芳香族化合物が得られる。   That is, in the production method of the present invention, the thiophene ring condensation reaction involving the cleavage of the C—H bond at the ortho position of the arylethynyl group proceeds by the number of triple bonds, and the thiophene ring is condensed for the number of times. A compound is obtained.

本発明において、基質として使用される多環芳香族化合物又は複素環式化合物は、上記のような一般式(1)で表される構造(例えば、一般式(1A)で表される構造、一般式(1B)で表される構造等)を1個以上(好ましくは1〜10の整数)有しているが、その数に制限はない。上記したとおり、一般式(1)で表される構造を有する数だけチオフェン環を縮環することができるため、チオフェン環を縮環しようとする数に応じて適宜設定することができる。具体的には、多環芳香族化合物又は複素環式化合物は、上記のような一般式(1)で表される構造を1個、2個、3個、4個又は5個有することもできる。   In the present invention, the polycyclic aromatic compound or heterocyclic compound used as a substrate is a structure represented by the general formula (1) as described above (for example, a structure represented by the general formula (1A), 1 or more (preferably an integer of 1 to 10), but the number is not limited. As described above, since the thiophene ring can be condensed by the number having the structure represented by the general formula (1), it can be appropriately set according to the number of the thiophene ring to be condensed. Specifically, the polycyclic aromatic compound or the heterocyclic compound may have one, two, three, four, or five structures represented by the general formula (1) as described above. .

なお、基質として使用される多環芳香族化合物又は複素環式化合物は、上記のような一般式(1)で表される構造を有しているが、この構造を構成する−(C≡C)n−R1で表される基が結合している多環芳香族炭化水素環又は複素環上の炭素原子と隣接している2つの炭素原子のうち、少なくとも1つの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合しているが、この隣接する2つの炭素原子ともに水素原子が結合している場合には、得られるチオフェン環縮合芳香族化合物には構造異性体が含まれる。このため、反応の効率等を考慮すると、一般式(1)で表される構造を構成する−(C≡C)n−R1で表される基が結合している多環芳香族炭化水素環又は複素環上の炭素原子と隣接している2つの炭素原子のうち、1つのみの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合していることが好ましい。 The polycyclic aromatic compound or heterocyclic compound used as the substrate has a structure represented by the general formula (1) as described above, and — (C≡C ) Of the two carbon atoms adjacent to the carbon atom on the polycyclic aromatic hydrocarbon ring or heterocyclic ring to which the group represented by n- R 1 is bonded, at least one carbon atom includes the above- When the group represented by (C≡C) n -R 1 is not bonded and a hydrogen atom is bonded, the hydrogen atom is bonded to the two adjacent carbon atoms. The thiophene ring-fused aromatic compound includes structural isomers. For this reason, considering the efficiency of the reaction, etc., the polycyclic aromatic hydrocarbon to which the group represented by — (C≡C) n —R 1 constituting the structure represented by the general formula (1) is bonded The group represented by-(C≡C) n -R 1 is not bonded to only one of the two carbon atoms adjacent to the carbon atom on the ring or heterocyclic ring. It is preferable that a hydrogen atom is bonded.

一般式(1)、(1A)及び(1B)において、R1で示されるアリール基としては、単環アリール基(フェニル基)及び多環アリール基(縮合環アリール基、多環非縮合環アリール基等)のいずれも採用でき、例えば、フェニル基、ナフチル基、アントラセニル基、ビフェニル基等が挙げられる。これらのなかでも、合成の容易さ、収率等の観点から、単環若しくは縮合環アリール基が好ましく、フェニル基がより好ましい。 In the general formulas (1), (1A) and (1B), the aryl group represented by R 1 includes a monocyclic aryl group (phenyl group) and a polycyclic aryl group (fused ring aryl group, polycyclic non-fused ring aryl). Group) and the like, and examples thereof include a phenyl group, a naphthyl group, an anthracenyl group, and a biphenyl group. Among these, from the viewpoints of ease of synthesis, yield, and the like, a monocyclic or condensed ring aryl group is preferable, and a phenyl group is more preferable.

R1で示されるアリール基は置換されていてもよい。R1で示されるアリール基が有し得る置換基としては、例えば、ハロゲン原子(フッ素原子、塩素原子、臭素原子、ヨウ素原子等)、アルキル基(メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、sec−ブチル基、tert−ブチル基、n−ヘキシル基、n−オクチル基等のC1−10アルキル基等)、ハロアルキル基(トリフルオロメチル基等のC1−6ハロアルキル基等)、アルコキシ基(メトキシ基、エトキシ基等のC1−6アルコキシ基)、アシル基(アセチル基、プロピオニル基等のC2−7アシル基等)、アルコキシカルボニル基(メトキシカルボニル基、エトキシカルボニル基等の(C1−6アルコキシ)カルボニル基等)、置換又は非置換アミノ基(アミノ基、ジメチルアミノ基、ジエチルアミノ基等のジ(C1−6アルキル)アミノ基等)、ニトロ基等が挙げられる。これらの置換基を有する場合、置換基の数は、1〜6個が好ましく、1〜3個がより好ましい。 一般式(1)において、nは1以上の整数である。nの数は縮環しようとするチオフェン環の数に応じて適宜設定できるが、合成の容易さ、収率等の観点から、1〜5の整数が好ましく、1〜3の整数がより好ましい。 The aryl group represented by R 1 may be substituted. Examples of the substituent that the aryl group represented by R 1 may have include a halogen atom (fluorine atom, chlorine atom, bromine atom, iodine atom, etc.), alkyl group (methyl group, ethyl group, n-propyl group, isopropyl). Group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-hexyl group, n-octyl group and other C1-10 alkyl groups), haloalkyl group (trifluoromethyl group and other C1- 6 haloalkyl group), alkoxy group (C1-6 alkoxy group such as methoxy group, ethoxy group, etc.), acyl group (C2-7 acyl group such as acetyl group, propionyl group, etc.), alkoxycarbonyl group (methoxycarbonyl group, ethoxy group) (C1-6 alkoxy) carbonyl group such as carbonyl group), substituted or unsubstituted amino group (di (C1-6 alkyl) such as amino group, dimethylamino group, diethylamino group) Amino group etc.) and a nitro group. In the case of having these substituents, the number of substituents is preferably 1 to 6, more preferably 1 to 3. In the general formula (1), n is an integer of 1 or more. The number of n can be appropriately set according to the number of thiophene rings to be condensed, but from the viewpoint of ease of synthesis, yield, etc., an integer of 1 to 5 is preferable and an integer of 1 to 3 is more preferable.

一般式(2A)及び(2B)において、R2は、R1と同一の基か、R1が還元された基であり、置換されていてもよいアリール基である。上記のとおり、R1がニトロ基を有する場合、チオフェン環の縮環反応の際に還元されてアミノ基になるため、R1がニトロ基で置換されたアリール基の場合は、R2はアミノ基で置換されたアリール基である。また、R1が非置換アリール基であるか、ニトロ基以外の置換基で置換されたアリール基である場合は、R2はR1と同じである。 In formula (2A) and (2B), R 2 is either same group as R 1, a group R 1 is reduced, an aryl group which may be substituted. As described above, when R 1 has a nitro group, it is reduced to an amino group during the condensation reaction of the thiophene ring. Therefore, when R 1 is an aryl group substituted with a nitro group, R 2 is an amino group. An aryl group substituted with a group. When R 1 is an unsubstituted aryl group or an aryl group substituted with a substituent other than a nitro group, R 2 is the same as R 1 .

このような条件を満たす一般式(1)で表される構造としては、例えば、   As a structure represented by the general formula (1) that satisfies such conditions, for example,

Figure 2017218381
Figure 2017218381

[式中、nBuはn−ブチル基を示す。tBuはtert−ブチル基を示す。nhexylはn−ヘキシル基を示す。noctylはn−オクチル基を示す。以下同様である。]
等で表される構造が挙げられる。
[Wherein n Bu represents an n-butyl group. t Bu represents a tert-butyl group. n hexyl represents an n-hexyl group. n octyl represents an n-octyl group. The same applies hereinafter. ]
The structure represented by etc. is mentioned.

このような構造を有する多環芳香族化合物又は複素環式化合物としては、具体的には、一般式(3):   Specifically, the polycyclic aromatic compound or heterocyclic compound having such a structure is represented by the general formula (3):

Figure 2017218381
Figure 2017218381

[式中、R1及びnは前記に同じである。Arは置換されていてもよい多環芳香族炭化水素環又は置換されていてもよい複素芳香環を示す。R3は−(C≡C)n−R1で表される基を示す。R3が結合しているAr環上の炭素原子と隣接している炭素原子の少なくとも1つの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合している。mは0以上の整数を示す。]
で表される化合物が好ましい。
[Wherein, R 1 and n are the same as defined above. Ar represents a polycyclic aromatic hydrocarbon ring which may be substituted or a heteroaromatic ring which may be substituted. R 3 represents a group represented by — (C≡C) n —R 1 . The group represented by-(C≡C) n -R 1 is not bonded to at least one carbon atom adjacent to the carbon atom on the Ar ring to which R 3 is bonded. Hydrogen atoms are bonded. m represents an integer of 0 or more. ]
The compound represented by these is preferable.

一般式(3)において、Arで示される多環芳香族炭化水素環としては、ナフタレン環、アントラセン環、フェナントレン環、テトラセン環、ピレン環、フルオランテン環、ペンタセン環、ペリレン環、コラニュレン環、クリセン環、ベンゾ[c]ナフト[2,1-p]クリセン環等が挙げられ、これらにベンゼン環を縮環したもの(コロネン環、トリフェニレン環、ヘキサベンゾコロネン環、テリレン環等)も挙げられる。Arで示される多環芳香族炭化水素環は置換されていてもよい。Arで示される多環芳香族炭化水素環が有し得る置換基としては、例えば、ハロゲン原子(フッ素原子、塩素原子、臭素原子、ヨウ素原子等)、アルキル基(メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、sec−ブチル基、tert−ブチル基、n−ヘキシル基、n−オクチル基等のC1−10アルキル基等)、ハロアルキル基(トリフルオロメチル基等のC1−6ハロアルキル基等)、アルコキシ基(メトキシ基、エトキシ基等のC1−6アルコキシ基)、アシル基(アセチル基、プロピオニル基等のC2−7アシル基等)、アルコキシカルボニル基(メトキシカルボニル基、エトキシカルボニル基等の(C1−6アルコキシ)カルボニル基等)、置換又は非置換アミノ基(アミノ基、ジメチルアミノ基、ジエチルアミノ基等のジ(C1−6アルキル)アミノ基等)、ニトロ基等が挙げられる。これらの置換基を有する場合、置換基の数は、1〜6個が好ましく、1〜3個がより好ましい。   In the general formula (3), the polycyclic aromatic hydrocarbon ring represented by Ar includes a naphthalene ring, anthracene ring, phenanthrene ring, tetracene ring, pyrene ring, fluoranthene ring, pentacene ring, perylene ring, corannulene ring, chrysene ring Benzo [c] naphtho [2,1-p] chrysene ring and the like, and those obtained by condensing a benzene ring (coronene ring, triphenylene ring, hexabenzocoronene ring, terylene ring, etc.). The polycyclic aromatic hydrocarbon ring represented by Ar may be substituted. Examples of the substituent that the polycyclic aromatic hydrocarbon ring represented by Ar may have include a halogen atom (fluorine atom, chlorine atom, bromine atom, iodine atom, etc.), alkyl group (methyl group, ethyl group, n- C1-10 alkyl group such as propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-hexyl group and n-octyl group), haloalkyl group (trifluoromethyl group) C1-6 haloalkyl groups, etc.), alkoxy groups (C1-6 alkoxy groups, such as methoxy groups and ethoxy groups), acyl groups (C2-7 acyl groups, such as acetyl groups and propionyl groups), alkoxycarbonyl groups (methoxy) (C1-6 alkoxy) carbonyl group such as carbonyl group and ethoxycarbonyl group), substituted or unsubstituted amino group (amino group, dimethylamino group, diethylamino group and other di (C1-6) Alkyl) amino group, etc.), and a nitro group. In the case of having these substituents, the number of substituents is preferably 1 to 6, more preferably 1 to 3.

一般式(3)において、Arで示される複素芳香環としては、例えば、チオフェン環、ベンゾチオフェン環、ジチエノベンゼン環等が挙げられ、これらにベンゼン環を縮環したものも挙げられる。Arで示される複素芳香環は置換されていてもよい。Arで示される多複素芳香環が有し得る置換基としては、例えば、ハロゲン原子(フッ素原子、塩素原子、臭素原子、ヨウ素原子等)、アルキル基(メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、sec−ブチル基、tert−ブチル基、n−ヘキシル基、n−オクチル基等のC1−10アルキル基等)、ハロアルキル基(トリフルオロメチル基等のC1−6ハロアルキル基等)、アルコキシ基(メトキシ基、エトキシ基等のC1−6アルコキシ基)、アシル基(アセチル基、プロピオニル基等のC2−7アシル基等)、アルコキシカルボニル基(メトキシカルボニル基、エトキシカルボニル基等の(C1−6アルコキシ)カルボニル基等)、置換又は非置換アミノ基(アミノ基、ジメチルアミノ基、ジエチルアミノ基等のジ(C1−6アルキル)アミノ基等)、ニトロ基等が挙げられる。これらの置換基を有する場合、置換基の数は、1〜6個が好ましく、1〜3個がより好ましい。   In the general formula (3), examples of the heteroaromatic ring represented by Ar include a thiophene ring, a benzothiophene ring, a dithienobenzene ring, and the like, and a ring condensed with a benzene ring. The heteroaromatic ring represented by Ar may be substituted. Examples of the substituent that the polyheteroaromatic ring represented by Ar may have include a halogen atom (fluorine atom, chlorine atom, bromine atom, iodine atom, etc.), alkyl group (methyl group, ethyl group, n-propyl group, C1-10 alkyl group such as isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-hexyl group and n-octyl group), haloalkyl group (C1 such as trifluoromethyl group) -6 haloalkyl group, etc.), alkoxy group (C1-6 alkoxy group such as methoxy group, ethoxy group, etc.), acyl group (C2-7 acyl group such as acetyl group, propionyl group, etc.), alkoxycarbonyl group (methoxycarbonyl group, (C1-6 alkoxy) carbonyl group such as ethoxycarbonyl group), substituted or unsubstituted amino group (di (C1-6 alkyl) such as amino group, dimethylamino group, diethylamino group) Amino group etc.) and a nitro group. In the case of having these substituents, the number of substituents is preferably 1 to 6, more preferably 1 to 3.

一般式(3)において、R3は−(C≡C)n−R1で表される基を示す。R3におけるR1及びnは上記したものを採用できる。このR3が結合しているAr環上の炭素原子と隣接している炭素原子の少なくとも1つの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合している。つまり、mが1以上である場合には、多環芳香族化合物又は複素環式化合物が、一般式(1)で表される構造を複数有していることを意味する。 In the general formula (3), R 3 represents a group represented by — (C≡C) n —R 1 . As R 1 and n in R 3 , those described above can be adopted. The group represented by-(C≡C) n -R 1 is bonded to at least one carbon atom adjacent to the carbon atom on the Ar ring to which R 3 is bonded. A hydrogen atom is bonded. That is, when m is 1 or more, it means that the polycyclic aromatic compound or the heterocyclic compound has a plurality of structures represented by the general formula (1).

また、一般式(3)において、R3の数であるmは、0以上の整数、好ましくは0〜10の整数である。このmは、0、1、2、3、4又は5とすることができる。つまり、多環芳香族化合物又は複素環式化合物は、一般式(1)で表される構造を、1個、2個、3個、4個、5個又は6個有することができる。 In the general formula (3), m which is the number of R 3 is an integer of 0 or more, preferably an integer of 0 to 10. This m can be 0, 1, 2, 3, 4 or 5. That is, the polycyclic aromatic compound or the heterocyclic compound can have one, two, three, four, five, or six structures represented by the general formula (1).

このような条件を満たす多環芳香族化合物又は複素環式化合物としては、例えば、一般式(3A):   Examples of the polycyclic aromatic compound or heterocyclic compound satisfying such conditions include, for example, the general formula (3A):

Figure 2017218381
Figure 2017218381

[式中、R1及びArは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物が挙げられる。
[Wherein, R 1 and Ar are the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
The compound represented by these is mentioned.

この化合物(3A)としては、例えば、   As this compound (3A), for example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、上記のような条件を満たす多環芳香族化合物又は複素環式化合物としては、例えば、一般式(3B):   Examples of the polycyclic aromatic compound or heterocyclic compound satisfying the above conditions include, for example, the general formula (3B):

Figure 2017218381
Figure 2017218381

[式中、R1及びArは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物も挙げられる。
[Wherein, R 1 and Ar are the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
The compound represented by these is also mentioned.

この化合物(3B)としては、例えば、   As this compound (3B), for example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、上記のような条件を満たす多環芳香族化合物又は複素環式化合物としては、例えば、一般式(3C):   Examples of the polycyclic aromatic compound or heterocyclic compound satisfying the above conditions include, for example, the general formula (3C):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。Arは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物も挙げられる。
[Wherein, R 1 is the same or different and is the same as defined above. Ar is the same as described above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
The compound represented by these is also mentioned.

この化合物(3C)としては、例えば、   As this compound (3C), for example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、上記のような条件を満たす多環芳香族化合物又は複素環式化合物としては、例えば、一般式(3D):   Examples of the polycyclic aromatic compound or heterocyclic compound satisfying the above conditions include, for example, the general formula (3D):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。Arは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物も挙げられる。
[Wherein, R 1 is the same or different and is the same as defined above. Ar is the same as described above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
The compound represented by these is also mentioned.

この化合物(3D)としては、例えば、   As this compound (3D), for example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、上記のような条件を満たす多環芳香族化合物又は複素環式化合物としては、例えば、一般式(3E):   Examples of the polycyclic aromatic compound or heterocyclic compound satisfying the above conditions include, for example, the general formula (3E):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。]
で表される化合物も挙げられる。
[Wherein, R 1 is the same or different and is the same as defined above. ]
The compound represented by these is also mentioned.

この化合物(3E)としては、例えば、   As this compound (3E), for example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、上記のような条件を満たす多環芳香族化合物又は複素環式化合物としては、例えば、一般式(3F):   Examples of the polycyclic aromatic compound or heterocyclic compound satisfying the above conditions include, for example, the general formula (3F):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。]
で表される化合物も挙げられる。
[Wherein, R 1 is the same or different and is the same as defined above. ]
The compound represented by these is also mentioned.

この化合物(3F)としては、例えば、   As this compound (3F), for example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

なお、本発明の製造方法では、エチニレン基と隣接するオルト位のC−H結合の切断を伴うチオフェン縮環反応が進行する。このため、エチニレン基と隣接する環(ベンゼン環等)等の結合を崩しながらチオフェン環縮環反応が進行する。このため、多環芳香族化合物及び複素環式化合物としては、環の数が大きい方が上記の縮環反応におけるエチニレン基と隣接する環(ベンゼン環等)の芳香族性が崩された場合の安定性に優れるために合成が容易且つ収率が高くなりやすい。このため、多環芳香族化合物及び複素環式化合物としては、環の数が大きいものを採用することが好ましい。   In the production method of the present invention, a thiophene condensed ring reaction involving the cleavage of the C—H bond at the ortho position adjacent to the ethynylene group proceeds. For this reason, the thiophene ring condensation reaction proceeds while breaking the bond between the ethynylene group and the adjacent ring (such as a benzene ring). For this reason, as a polycyclic aromatic compound and a heterocyclic compound, when the number of rings is larger, the aromaticity of the ring (benzene ring, etc.) adjacent to the ethynylene group in the above-mentioned condensed ring reaction is destroyed. Since the stability is excellent, the synthesis is easy and the yield tends to be high. For this reason, it is preferable to employ a polycyclic aromatic compound and a heterocyclic compound having a large number of rings.

また、上記した多環芳香族化合物及び複素環式化合物は、事前に調製してから投入してもよいし、系中で(例えば薗頭カップリング、右田・小杉・スティルカップリング等により)合成してもよい。つまり、アリールトリフラート及びアルキンから薗頭カップリング反応、右田・小杉・スティルカップリング等を経て、チオフェン環縮環反応をワンポットで行うことも可能である。   The polycyclic aromatic compound and the heterocyclic compound described above may be added after being prepared in advance, or synthesized in the system (for example, by Sonogashira coupling, Ueda / Kosugi / Still coupling, etc.). May be. That is, the thiophene ring-condensation reaction can be carried out in one pot from aryl triflate and alkyne via Sonogashira coupling reaction, Ueda, Kosugi, Stille coupling and the like.

本発明では、上記した多環芳香族炭化水素環又は複素芳香環に対してチオフェン環を縮環させるための硫黄源として、硫黄(単体硫黄)を使用する。硫黄の使用量は、多環芳香族化合物及び複素環式化合物が有する−(C≡C)n−R1で表される基の数(nの値)によって適宜設定することができる。例えば、nが0である場合は、硫黄の使用量は、多環芳香族化合物又は複素環式化合物中の−(C≡C)n−R1で表される基1モルに換算して、0.2〜5.0モルが好ましく、0.3〜4.0モルがより好ましい。 In the present invention, sulfur (single sulfur) is used as a sulfur source for condensing a thiophene ring with respect to the above polycyclic aromatic hydrocarbon ring or heteroaromatic ring. The amount of sulfur used can be appropriately set depending on the number of groups represented by — (C≡C) n —R 1 (value of n) possessed by the polycyclic aromatic compound and the heterocyclic compound. For example, when n is 0, the amount of sulfur used is converted to 1 mol of the group represented by-(C≡C) n -R 1 in the polycyclic aromatic compound or heterocyclic compound, 0.2-5.0 mol is preferable and 0.3-4.0 mol is more preferable.

本発明において、多環芳香族炭化水素環又は複素芳香環と硫黄との反応条件は特に制限されない。通常は、多環芳香族炭化水素環又は複素芳香環と、硫黄とを、必要に応じて撹拌しながら溶媒中で加熱する手法が簡便で且つ高収率にチオフェン環縮合芳香族化合物を得ることができる。   In the present invention, the reaction conditions between the polycyclic aromatic hydrocarbon ring or heteroaromatic ring and sulfur are not particularly limited. Usually, a method of heating a polycyclic aromatic hydrocarbon ring or heteroaromatic ring and sulfur in a solvent with stirring as necessary is simple and obtains a thiophene ring condensed aromatic compound in a high yield. Can do.

この際使用できる溶媒としては、極性溶媒であることが好ましい。このような極性溶媒を採用することにより、より高収率にチオフェン環縮合芳香族化合物を得ることができる。このような溶媒としては、プロトン性極性溶媒及び非プロトン性極性溶媒のいずれも採用でき、プロトン性極性溶媒としては、例えば、1,4−ジオキサン、テトラヒドロフラン、アニソール、シクロペンチルメチルエーテル、酢酸エチル等が挙げられる。また、非プロトン性極性溶媒としては、例えば、ジメチルスルホキシド、アミド系溶媒(N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、N−メチルピロリドン等)、ニトリル系溶媒(アセトニトリル、プロピオニトリル等)等が挙げられる。なかでも、後述する反応温度よりも沸点が高い溶媒が好ましく、1,4−ジオキサン、アニソール、シクロペンチルメチルエーテル、ジメチルスルホキシド、アミド系溶媒(N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、N−メチルピロリドン等)等が好ましく、アニソール、ジメチルスルホキシド、アミド系溶媒(N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、N−メチルピロリドン等)等がより好ましい。なお、これらの溶媒に対して、メタノール、エタノール等のアルコールを併用した場合には、反応速度をさらに加速させることも可能である。   The solvent that can be used at this time is preferably a polar solvent. By employing such a polar solvent, a thiophene ring condensed aromatic compound can be obtained with higher yield. As such a solvent, both a protic polar solvent and an aprotic polar solvent can be adopted. Examples of the protic polar solvent include 1,4-dioxane, tetrahydrofuran, anisole, cyclopentyl methyl ether, ethyl acetate, and the like. Can be mentioned. Examples of the aprotic polar solvent include dimethyl sulfoxide, amide solvents (N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, etc.), nitrile solvents (acetonitrile, propionitrile, etc.). ) And the like. Among them, a solvent having a boiling point higher than the reaction temperature described later is preferable, and 1,4-dioxane, anisole, cyclopentylmethyl ether, dimethyl sulfoxide, amide solvents (N, N-dimethylformamide, N, N-dimethylacetamide, N -Methylpyrrolidone and the like) are preferred, and anisole, dimethyl sulfoxide, amide solvents (N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone and the like) and the like are more preferred. In addition, when alcohol, such as methanol and ethanol, is used in combination with these solvents, the reaction rate can be further accelerated.

加熱温度は、本発明の縮環反応が進行すれば特に制限はない。具体的には、収率等の観点から、100〜180℃が好ましく、120〜160℃がより好ましく、130〜150℃がさらに好ましい。加熱時間は、本発明の縮環反応が十分に進行する時間とすればよく、例えば、10分〜96時間が好ましく、30分〜72時間がより好ましい。なお、反応雰囲気は、不活性ガス(窒素ガス、アルゴンガス等)雰囲気が好ましい。   The heating temperature is not particularly limited as long as the ring condensation reaction of the present invention proceeds. Specifically, from the viewpoint of yield and the like, 100 to 180 ° C is preferable, 120 to 160 ° C is more preferable, and 130 to 150 ° C is more preferable. The heating time may be a time during which the ring condensation reaction of the present invention proceeds sufficiently. For example, 10 minutes to 96 hours are preferable, and 30 minutes to 72 hours are more preferable. The reaction atmosphere is preferably an inert gas (nitrogen gas, argon gas, etc.) atmosphere.

反応終了後は、必要に応じて通常の単離及び精製工程を経て、目的化合物である本発明のチオフェン環縮合芳香族化合物を得ることができる。   After completion of the reaction, the thiophene ring-condensed aromatic compound of the present invention, which is the target compound, can be obtained through ordinary isolation and purification steps as necessary.

2.チオフェン環縮合芳香族化合物
上記のようにして得られる本発明のチオフェン環縮合芳香族化合物は、置換基を有していてもよい多環芳香族炭化水素環に、1個以上の置換基を有していてもよいチオフェン環が縮合したチオフェン環縮合芳香族化合物である。
2. Thiophene ring condensed aromatic compound The thiophene ring condensed aromatic compound of the present invention obtained as described above has one or more substituents on the polycyclic aromatic hydrocarbon ring which may have a substituent. It is a thiophene ring condensed aromatic compound in which a thiophene ring which may be condensed is condensed.

このチオフェン環縮合芳香族化合物のうち、基質として、一般式(3)で表され、Arが多環芳香族炭化水素環である化合物を用いた場合に得られるチオフェン環縮合芳香族化合物は、ナフタレン環に置換基を有していてもよいチオフェン環が2個縮合した化合物、アントラセン環に置換基を有していてもよいチオフェン環が1個又は4個縮合した化合物、及びアントラキノンに置換基を有していてもよいチオフェン環が1個縮合した化合物を除き、文献未記載の新規化合物である。   Among these thiophene ring-fused aromatic compounds, the thiophene ring-fused aromatic compound obtained when the compound represented by the general formula (3) and Ar is a polycyclic aromatic hydrocarbon ring is used as a substrate. A compound in which two thiophene rings optionally having a substituent are condensed, a compound in which one or four thiophene rings optionally having a substituent in an anthracene ring are condensed, and anthraquinone are substituted. Except for a compound in which one thiophene ring which may have is condensed, it is a novel compound not described in any literature.

このようなチオフェン環縮合芳香族化合物は、基質として一般式(3A)で表される化合物を使用した場合は、一般式(4A):   Such a thiophene-ring-fused aromatic compound is represented by the general formula (4A) when the compound represented by the general formula (3A) is used as a substrate:

Figure 2017218381
Figure 2017218381

[式中、R1及びArは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物である。
[Wherein, R 1 and Ar are the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
It is a compound represented by these.

R1は前記したものが挙げられる。Arも前記したものが挙げられ、置換基を有していてもよいナフタレン環、置換基を有していてもよいフェナントレン環、置換基を有していてもよいテトラセン環、置換基を有していてもよいピレン環、置換基を有していてもよいフルオランテン環、置換基を有していてもよいペンタセン環、置換基を有していてもよいペリレン環、置換基を有していてもよいコラニュレン環、置換基を有していてもよいクリセン環、又は置換基を有していてもよいベンゾ[c]ナフト[2,1-p]クリセン環である場合に新規化合物である。置換基としては、上記したものを採用できる。 Examples of R 1 include those described above. Examples of Ar also include those described above, which may have a naphthalene ring which may have a substituent, a phenanthrene ring which may have a substituent, a tetracene ring which may have a substituent, and a substituent. A pyrene ring which may have a substituent, a fluoranthene ring which may have a substituent, a pentacene ring which may have a substituent, a perylene ring which may have a substituent, and a substituent. The compound is a novel compound when the ring is a corannulene ring, a chrysene ring which may have a substituent, or a benzo [c] naphtho [2,1-p] chrysene ring which may have a substituent. As the substituent, those described above can be adopted.

例えば、   For example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、チオフェン環縮合芳香族化合物は、基質として一般式(3B)で表される化合物を使用した場合は、一般式(4B):   Further, the thiophene ring condensed aromatic compound, when the compound represented by the general formula (3B) is used as a substrate, the general formula (4B):

Figure 2017218381
Figure 2017218381

[式中、R1及びArは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物である。
[Wherein, R 1 and Ar are the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
It is a compound represented by these.

R1は前記したものが挙げられる。Arも前記したものが挙げられ、置換基を有していてもよいナフタレン環、置換基を有していてもよいアントラセン環、置換基を有していてもよいフェナントレン環、置換基を有していてもよいテトラセン環、置換基を有していてもよいピレン環、置換基を有していてもよいフルオランテン環、置換基を有していてもよいペンタセン環、置換基を有していてもよいペリレン環、置換基を有していてもよいコラニュレン環、置換基を有していてもよいクリセン環、又は置換基を有していてもよいベンゾ[c]ナフト[2,1-p]クリセン環である場合に新規化合物である。置換基としては、上記したものを採用できる。 Examples of R 1 include those described above. Examples of Ar also include those described above, which may have a naphthalene ring which may have a substituent, an anthracene ring which may have a substituent, a phenanthrene ring which may have a substituent, and a substituent. A tetracene ring which may have a substituent, a pyrene ring which may have a substituent, a fluoranthene ring which may have a substituent, a pentacene ring which may have a substituent, and a substituent. Perylene ring, optionally substituted coranulene ring, optionally substituted chrysene ring, or optionally substituted benzo [c] naphtho [2,1-p ] A new compound when it is a chrysene ring. As the substituent, those described above can be adopted.

例えば、   For example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、チオフェン環縮合芳香族化合物は、基質として一般式(3C)で表される化合物を使用した場合は、一般式(4C):   Moreover, the thiophene ring condensed aromatic compound, when the compound represented by the general formula (3C) is used as a substrate, the general formula (4C):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。Arは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物である。
[Wherein, R 1 is the same or different and is the same as defined above. Ar is the same as described above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
It is a compound represented by these.

R1は前記したものが挙げられる。Arも前記したものが挙げられ、置換基を有していてもよいアントラセン環、置換基を有していてもよいフェナントレン環、置換基を有していてもよいテトラセン環、置換基を有していてもよいピレン環、置換基を有していてもよいフルオランテン環、置換基を有していてもよいペンタセン環、置換基を有していてもよいペリレン環、置換基を有していてもよいコラニュレン環、置換基を有していてもよいクリセン環、又は置換基を有していてもよいベンゾ[c]ナフト[2,1-p]クリセン環である場合に新規化合物である。置換基としては、上記したものを採用できる。 Examples of R 1 include those described above. Examples of Ar also include those described above. An anthracene ring which may have a substituent, a phenanthrene ring which may have a substituent, a tetracene ring which may have a substituent, and a substituent A pyrene ring which may have a substituent, a fluoranthene ring which may have a substituent, a pentacene ring which may have a substituent, a perylene ring which may have a substituent, and a substituent. The compound is a novel compound when the ring is a corannulene ring, a chrysene ring which may have a substituent, or a benzo [c] naphtho [2,1-p] chrysene ring which may have a substituent. As the substituent, those described above can be adopted.

例えば、   For example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、チオフェン環縮合芳香族化合物は、基質として一般式(3D)で表される化合物を使用した場合は、一般式(4D):   Moreover, the thiophene ring condensed aromatic compound, when the compound represented by the general formula (3D) is used as a substrate, the general formula (4D):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。Arは前記に同じである。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される化合物である。
[Wherein, R 1 is the same or different and is the same as defined above. Ar is the same as described above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
It is a compound represented by these.

R1は前記したものが挙げられる。Arも前記したものが挙げられ、置換基を有していてもよいアントラセン環、置換基を有していてもよいフェナントレン環、置換基を有していてもよいテトラセン環、置換基を有していてもよいピレン環、置換基を有していてもよいフルオランテン環、置換基を有していてもよいペンタセン環、置換基を有していてもよいペリレン環、置換基を有していてもよいコラニュレン環、置換基を有していてもよいクリセン環、又は置換基を有していてもよいベンゾ[c]ナフト[2,1-p]クリセン環である場合に新規化合物である。置換基としては、上記したものを採用できる。 Examples of R 1 include those described above. Examples of Ar also include those described above. An anthracene ring which may have a substituent, a phenanthrene ring which may have a substituent, a tetracene ring which may have a substituent, and a substituent A pyrene ring which may have a substituent, a fluoranthene ring which may have a substituent, a pentacene ring which may have a substituent, a perylene ring which may have a substituent, and a substituent. The compound is a novel compound when the ring is a corannulene ring, a chrysene ring which may have a substituent, or a benzo [c] naphtho [2,1-p] chrysene ring which may have a substituent. As the substituent, those described above can be adopted.

例えば、   For example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、チオフェン環縮合芳香族化合物は、基質として一般式(3E)で表される化合物を使用した場合は、一般式(4E):   In addition, the thiophene ring-fused aromatic compound, when the compound represented by the general formula (3E) is used as a substrate, the general formula (4E):

Figure 2017218381
Figure 2017218381

[式中、R1は同一又は異なって、前記に同じである。]
で表される化合物である。
[Wherein, R 1 is the same or different and is the same as defined above. ]
It is a compound represented by these.

R1は前記したものが挙げられ、新規化合物である。 Examples of R 1 are those described above and are novel compounds.

例えば、   For example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

また、チオフェン環縮合芳香族化合物は、基質として一般式(3F)で表される化合物を使用した場合は、一般式(4F):   Moreover, the thiophene ring condensed aromatic compound, when the compound represented by the general formula (3F) is used as a substrate, the general formula (4F):

Figure 2017218381
Figure 2017218381

で表される化合物である。 It is a compound represented by these.

R1は前記したものが挙げられ、新規化合物である。 Examples of R 1 are those described above and are novel compounds.

例えば、   For example,

Figure 2017218381
Figure 2017218381

等が挙げられる。 Etc.

以下、本発明について、実施例を挙げて具体的に説明するが、本発明は、これらの実施例に何ら制約されるものではない。   EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated concretely, this invention is not restrict | limited at all by these Examples.

特に制約しない限り、乾燥溶媒を含む全ての材料は、市販品を精製せずに使用した。また、全ての溶媒は、乾燥溶媒を使用した。化合物1a〜1wは、既報にしたがって合成した。すべての反応は、標準的な真空ライン技法及びシュレンク技法を用いて行った。すべての後処理及び精製手順は、空気中で試薬グレードの溶媒を用いて行った。   Unless otherwise restricted, all materials including dry solvents were used without purification of commercial products. Moreover, the dry solvent was used for all the solvents. Compounds 1a-1w were synthesized according to previous reports. All reactions were performed using standard vacuum line and Schlenk techniques. All work-up and purification procedures were performed in air with reagent grade solvents.

分析用薄層クロマトグラフィー(TLC)は、E. Merckシリカゲル60 F254プレコートプレート(0.25 mm)を用いて行った。得られたクロマトグラムは、UVランプ(254 nm)で分析した。フラッシュカラムクロマトグラフィーは、E. Merckシリカゲル60(230-400メッシュ)を用いて行った。分取リサイクルゲルパーミエーションクロマトグラフィー(GPC)は、溶離液としてクロロホルムを用いてJAIGEL-1H/JAIGEL-2Hカラムを備えたJAI LC-9260 II NEXTを用いて行った。高分解能質量スペクトル(HRMS)は、Bruker Daltonics Ultraflex III TOF/TOF (MALDI-TOF-MS)で行った。核磁気共鳴(NMR)スペクトルは、UltraCool probe(1H 500 MHz、13C 125MHz)を備えたJEOL ECA 500II分光計で記録した。1H NMRの化学シフトはCHCl3(δ7.26 ppm)の相対的な百万分率(ppm)で表した。13C NMRのchemical shiftはCDCl3(δ77.0 ppm)の相対的な百万分率(ppm)で表した。データは、chemical shift、multiplicity(s =singlet、d =doublet、t =triplet、m=multiplet)、couplinh constant(Hz)、及びintegrationの順に報告する。 Analytical thin layer chromatography (TLC) was performed using E. Merck silica gel 60 F254 precoated plates (0.25 mm). The obtained chromatogram was analyzed with a UV lamp (254 nm). Flash column chromatography was performed using E. Merck silica gel 60 (230-400 mesh). Preparative recycle gel permeation chromatography (GPC) was performed using a JAI LC-9260 II NEXT equipped with a JAIGEL-1H / JAIGEL-2H column with chloroform as the eluent. High resolution mass spectra (HRMS) were performed on a Bruker Daltonics Ultraflex III TOF / TOF (MALDI-TOF-MS). Nuclear magnetic resonance (NMR) spectra were recorded on a JEOL ECA 500II spectrometer equipped with an UltraCool probe ( 1 H 500 MHz, 13 C 125 MHz). 1 H NMR chemical shifts were expressed as relative parts per million (ppm) of CHCl 3 (δ 7.26 ppm). The chemical shift of 13 C NMR was expressed in relative parts per million (ppm) of CDCl 3 (δ77.0 ppm). Data is reported in the order of chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), couplinh constant (Hz), and integration.

[実施例1:チオフェン環縮環反応]
実施例1−1:化合物2aの合成
[Example 1: Thiophene ring condensation reaction]
Example 1-1: Synthesis of compound 2a

Figure 2017218381
Figure 2017218381

外気中で、化合物1a(17.8 g, 53.2 mmol, 1.0当量)、硫黄(S8; 13.6 g, 53.2 mmol, 1.0当量)をシュレンクチューブに投入した。通常のシュレンク技法(evacuate-refill cycle)を用いて、チューブをアルゴンで充填した。チューブにジメチルホルムアミド(DMF; 200 mL)を入れ、混合物を140℃で36時間加熱した。次に、混合物を室温まで冷却した。得られた溶液を真空下に濃縮した。さらに、CH2Cl2/メタノール溶液からの再結晶により精製し、目的化合物2aを得た(18.0 g, 93%収率)。本実施例は、後述の表1のentry 1に相当する。
1H NMR (500 MHz, CDCl3) δ 8.72-8.68 (m, 2H), 8.36 (dd, J = 7, 2 Hz, 1H), 8.15-8.13 (m, 2H), 7.77 (d, J= 9 Hz, 2H), 7.68-7.61 (m, 4H) 7.50 (d, J = 9 Hz, 2H), 1.39 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 151.3, 143.4, 135.9, 135.8, 131.5, 129.1, 128.7, 128.5, 128.2, 127.2, 127.0, 126.1, 126.0, 124.2, 124.1, 123.6, 123.5, 118.3, 34.7, 31.3; HRMS (ESI-MS) m/zcalcd for C26H22S [M+H]+: 367.1515, found: 367.1507。
In the open air, compound 1a (17.8 g, 53.2 mmol, 1.0 equivalent) and sulfur (S 8 ; 13.6 g, 53.2 mmol, 1.0 equivalent) were added to a Schlenk tube. The tube was filled with argon using the usual Schlenk technique (evacuate-refill cycle). The tube was charged with dimethylformamide (DMF; 200 mL) and the mixture was heated at 140 ° C. for 36 hours. The mixture was then cooled to room temperature. The resulting solution was concentrated under vacuum. Further purification by recrystallization from CH 2 Cl 2 / methanol solution gave the target compound 2a (18.0 g, 93% yield). This embodiment corresponds to entry 1 in Table 1 described later.
1 H NMR (500 MHz, CDCl 3 ) δ 8.72-8.68 (m, 2H), 8.36 (dd, J = 7, 2 Hz, 1H), 8.15-8.13 (m, 2H), 7.77 (d, J = 9 Hz, 2H), 7.68-7.61 (m, 4H) 7.50 (d, J = 9 Hz, 2H), 1.39 (s, 9H); 13 C NMR (125 MHz, CDCl 3 ) δ 151.3, 143.4, 135.9, 135.8 , 131.5, 129.1, 128.7, 128.5, 128.2, 127.2, 127.0, 126.1, 126.0, 124.2, 124.1, 123.6, 123.5, 118.3, 34.7, 31.3; HRMS (ESI-MS) m / zcalcd for C 26 H 22 S (M + H] + : 367.1515, found: 367.1507.

なお、この反応において、化合物1a、硫黄(S8)及びDMFについて、それぞれパラジウム濃度を測定したところ、いずれも1 ppm未満(測定限界未満)であった。このことから、本発明のチオフェン環縮環反応は触媒反応ではなく、触媒は不要であることが理解できる。 In this reaction, the palladium concentration of compound 1a, sulfur (S 8 ), and DMF was measured and found to be less than 1 ppm (less than the measurement limit). From this, it can be understood that the thiophene ring condensation reaction of the present invention is not a catalytic reaction, and no catalyst is required.

実施例1−2:化合物2bの合成
以下の表1に示す条件とすること以外は実施例1−1と同様に、目的化合物2bを得た。なお、entry 1ではCH2Cl2/メタノール溶液からの再結晶により精製し、entry 2〜3、6〜7、12〜13及び16〜20ではGPCにより精製し、entry 4ではTLC(n−ヘキサン/酢酸エチル/CH2Cl2= 20:1:2)により精製し、entry 5、8〜9及び15ではTLC(n−ヘキサン/CH3Cl= 10:1)により精製し、entry 10〜11ではTLC(n−ヘキサン/CH3Cl= 5:1)により精製し、entry 14ではTLC(n−ヘキサン/CH3Cl = 5:2)により精製した。
Example 1-2: Synthesis of Compound 2b The target compound 2b was obtained in the same manner as in Example 1-1 except that the conditions shown in Table 1 below were used. In addition, it is purified by recrystallization from a CH 2 Cl 2 / methanol solution for entry 1, purified by GPC for entries 2 to 3, 6 to 7, 12 to 13, and 16 to 20, and TLC (n-hexane for entry 4 / Ethyl acetate / CH 2 Cl 2 = 20: 1: 2), and for entry 5, 8-9 and 15, purified by TLC (n-hexane / CH 3 Cl = 10: 1), entry 10-11 And purified by TLC (n-hexane / CH 3 Cl = 5: 1), and entry 14 was purified by TLC (n-hexane / CH 3 Cl = 5: 2).

Figure 2017218381
Figure 2017218381

Figure 2017218381
Figure 2017218381

Figure 2017218381
Figure 2017218381

Figure 2017218381
Figure 2017218381

Figure 2017218381
Figure 2017218381

なお、得られた各化合物のスペクトルデータは以下の通りである。
化合物2b:
1H NMR (500 MHz, CDCl3) δ 8.36 (d, J = 9 Hz, 1H), 8.16 (s, 1H), 7.94 (d, J = 8 Hz, 1H), 7.84 (d, J = 8 Hz, 1H), 7.73-7.69 (m, 3H), 7.62 (t, J = 8 Hz, 1H), 7.53 (t, J = 8 Hz, 1H), 7.27 (d, J = 8 Hz, 2H), 2.42 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 144.2, 138.1, 136.9, 136.8, 131.7, 131.1, 129.7, 129.2, 128.6, 126.4, 126.2, 125.2, 124.8, 123.5, 120.5, 117.1, 21.2; HRMS (DART-MS) m/zcalcd for C15H15S [M+H]+: 275.0889, found: 275.0911。
化合物2c:
1H NMR (500 MHz, CDCl3) δ 8.12 (d, J= 8 Hz, 1H), 7.91 (d, J= 8 Hz, 1H), 7.78 (d, J= 9 Hz, 1H), 7.72 (d, J= 9 Hz, 1H), 7.67 (d, J = 8 Hz, 2H), 7.62 (s, 1H), 7.57 (t, J = 8 Hz, 1H), 7.50 (t, J = 8 Hz, 1H), 2.41 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 137.6, 135.0, 134.6, 133.7, 132.9, 129.4, 129.0, 128.2, 127.9, 127.8, 127.7, 126.5, 126.4, 126.3, 125.8, 123.5, 21.3; HRMS (ESI-MS) m/z calcd for C15H15S [M+H]+: 275.0889, found: 275.0882。
化合物2d:
1H NMR (500 MHz, CDCl3) δ 8.01 (s, 1H), 7.73 (t, J = 9 Hz, 2H), 7.51 (d, J = 8 Hz, 2H), 7.44 (t, J = 7 Hz, 1H), 7.35 (t, J = 7 Hz, 1H), 7.17 (d, J= 8 Hz, 2 H), 7.13 (s, 1H), 4.02 (s, 3H), 2.63 (t, J = 8 Hz, 2H), 1.62 (quint, J = 7 Hz, 2H), 1.37 (sext, J = 7 Hz, 2H), 0.94 (t, J = 7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 153.2, 143.1, 143.0, 138.0, 132.4, 132.2, 131.8, 129.0, 127.6, 126.2, 125.8, 124.8, 124.2, 123.3, 116.8, 55.4, 35.4, 33.5,22.4, 14.0; HRMS (ESI-MS) m/z calcd for C23H22OS [M+H]+: 347.1464, found: 347.1458。
化合物2e:
1H NMR (500 MHz, CDCl3) δ 8.03 (d, J= 8 Hz, 1H), 7.90 (s, 1H), 7.79 (d, J= 8 Hz, 1H), 7.75 (s, 1H), 7.68 (d, J= 9 Hz, 2H), 7.55 (t, J = 8 Hz, 1H), 7.48 (t, J= 8 Hz, 1H), 7.25 (d, J= 9 Hz, 2H), 2.66 (t, J = 8 Hz, 2H), 1.64 (quint, J= 7 Hz, 2H), 1.39 (sext, J = 7 Hz, 2H), 0.95 (t, J = 7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 144.0, 143.6, 138.0, 137.0, 131.5, 131.3, 129.1, 128.0, 127.9, 127.8, 126.9, 126.3, 126.2, 123.5, 120.5, 115.6, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m/z calcd for C22H19BrS [M+H]+: 395.0464, found: 395.0457。
化合物2f:
1H NMR (500 MHz, CDCl3) δ 8.45 (s, 1H), 8.34 (d, J = 9 Hz, 1H), 8.23 (d, J = 1 Hz, 1H), 8.20 (d, J = 9 Hz, 1H), 8.19 (s, 1H), 8.04 (d, J = 9 Hz, 1H), 7.96 (d, J = 9 Hz, 1H), 7.89 (s, 1H), 7.77 (d, J = 8 Hz, 2H), 7.30 (d, J = 8 Hz, 2H), 2.44 (s, 3H), 1.60 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 148.8, 144.3, 138.8, 138.4, 134.9, 131.6, 131.0, 130.8, 129.7, 129.1, 128.2, 127.8, 126.9, 126.6, 125.3, 123.4, 122.5, 122.4, 122.1, 119.7, 119.3, 35.2, 31.9, 21.3; HRMS (ESI-MS) m/z calcd for C29H24S [M+H]+: 405.1671, found: 405.1666。
化合物2g:
1H NMR (500 MHz, CDCl3) δ 8.30 (s, 1H), 8.22 (d, J= 8 Hz, 1H), 8.18 (s, 1H), 7.97 (d, J= 7.0 Hz, 1H), 7.95-7.92 (m, 2H), 7.75-7.72 (m, 3H), 7.40-7.38 (m, 2H), 7.29 (d, J = 8 Hz, 2H), 2.68 (t, J = 8 Hz, 2H), 1.67 (quint, J = 7 Hz, 2H), 1.41 (sext, J = 7 Hz, 2H), 0.97 (t, J = 7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 145.6, 143.4, 140.1, 139.2, 138.9, 137.02, 136.98, 133.7, 131.7, 131.0, 129.1, 128.0, 127.5, 127.4, 126.2, 126.0, 122.6, 121.5, 121.3, 119.0, 117.2, 115.3, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m/z calcd for C28H22S [M+H]+: 391.1515, found: 391.1507。
化合物2h:
1H NMR (500 MHz, CDCl3) δ 8.61 (d, J= 8 Hz, 1H), 8.40 (d, J= 7 Hz, 1H), 8.30 (s, 1H), 8.18 (d, J= 7 Hz, 1H), 8.15 (d, J= 8 Hz, 1H), 8.10-8.00 (m, 4H), 7.80 (d, J = 8 Hz, 2H), 7.32 (d, J= 8 Hz, 2H), 2.70 (t, J = 8 Hz, 2H), 1.68 (quint, J = 7 Hz, 2H), 1.43 (sext, J = 7 Hz, 2H), 0.98 (t, J = 7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 143.9, 143.1, 136.3, 135.9, 131.7, 131.7, 129.1, 127.7, 127.3, 126.14, 126.08, 125.9, 125.0, 124.8, 123.4, 122.9, 121.0, 120.5, 118.4, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m/z calcd for C28H22S [M+H]+: 391.1515, found: 391.1508。
化合物2i:
1H NMR (500 MHz, CDCl3) δ 8.20 (s, 1H), 8.07 (d, J = 9 Hz, 1H), 7.95 (d, J = 9 Hz, 1H), 7.88 (d, J = 9 Hz, 1H), 7.86 (d, J = 9 Hz, 1H), 7,82-7.76 (m, 6H), 7.52 (d, J = 9 Hz, 1H), 1.40 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 151.5,144.6, 138.6, 136.5, 136.0, 135.55, 135.48, 134.4, 133.6, 131.5, 130.8, 129.9, 129.6, 127.8, 127.7, 127.5, 127.1, 127.0, 126.71, 126.68, 126.03, 125.98, 124.8, 124.5, 118.2, 34.7, 31.3; HRMS (ESI-MS) m/zcalcd for C32H22S [M+H]+: 439.1515, found: 439.1508。
化合物2j:
1H NMR (500 MHz, CDCl3) δ 8.01 (d, J = 9 Hz, 2H), 7.87 (d, J = 9 Hz, 2H), 7.70 (d, J = 8 Hz, 4H), 7.65 (s, 2H), 7.27 (d, J = 8 Hz, 4H), 2.67 (t, J = 8 Hz, 2H), 1.66 (quint, J = 7 Hz, 2H), 1.41 (sext, J = 7 Hz, 2H), 0.97 (t, J = 7 Hz, 3H); 13C NMR (125 MHz, C2D2Cl4) δ 143.5, 143.3, 138.1, 137.5, 131.3, 129.0, 126.1, 125.5, 122.6, 121.2, 120.1, 35.3, 33.4, 22.6, 14.0; HRMS (ESI-MS) m/zcalcd for C34H32S2 [M+H]+: 505.2018, found: 505.2010。
化合物2k:
1H NMR (500 MHz, CDCl3) δ 8.38 (dd, J = 6, 3 Hz, 2H), 8.14 (s, 2H), 7.72 (d, J = 8 Hz, 4H), 7.63 (dd, J = 6, 3 Hz, 2H), 7.28 (d, J = 8 Hz, 4H), 2.68 (t, J = 8 Hz, 4H), 1.67 (quint, J = 7 Hz, 4H), 1.42 (sext, J = 7 Hz, 4H), 0.97 (t, J = 7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 143.0, 142.2, 135.0, 131.6, 131.0, 129.0, 127.5, 126.0, 125.6, 124.3, 117.6, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m/zcalcd for C34H32S2 [M+H]+: 505.2018, found: 505.2008。
化合物2l:
1H NMR (500 MHz, CDCl3) δ 8.33 (d, J = 8 Hz, 1H), 8.12 (d, J = 8 Hz, 1H), 8.11 (s, 1H), 7.72 (s, 1H), 7.71 (d, J = 7 Hz, 4H), 7.58-7.40 (m, 2H), 7.26 (d, J = 7 Hz, 4H), 2.67 (t, J = 8 Hz, 4H), 1.66 (quint, J = 7 Hz, 4H), 1.41 (sext, J = 7 Hz, 4H), 0.97 (t, J = 7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 144.8, 143.4, 143.0, 142.5, 135.4, 133.9, 132.9, 132.2, 131.8, 131.5, 129.1, 127.3, 127.1, 126.2, 126.1, 125.94, 125.89, 124.58, 124.2, 117.7, 117.5, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m/z calcd for C34H32S2 [M+H]+: 505.2018, found: 505.2010。
化合物2m:
1H NMR (500 MHz, CDCl3, 25℃) δ 7.9 (s, 4H), 7.81 (d, J = 8.0 Hz, 4H), 7.78 (s, 2H), 7.30 (d, J = 8.0 Hz, 4H), 2.68 (t, J = 7.8 Hz, 2H), 1.70-1.64 (m, 4H), 1.40-1.31 (m, 12H), 0.92-0.89 (m, 6H); 13C NMR (125 MHz, CDCl3, 25℃) δ 145.2, 143.4, 140.8, 139.0, 133.5, 131.7, 129.1, 129.0, 126.5, 126.1, 124.3, 121.4, 119.8, 35.8, 31.7, 31.4, 29.0, 22.6, 14.1; HRMS (ESI-MS) m/z calcd for C38H40S2[M+H]+: 561.2644, found: 561.2632。
化合物2n:
1H NMR (500 MHz, CDCl3) δ 9.36 (dd, J = 8, 2 Hz, 2H), 8.50 (dd, J = 8, 2 Hz, 2H), 8.22 (s, 2H), 7.79 (d, J = 8 Hz, 4H), 7.79-7.75 (m, 4H), 7.29 (d, J = 8 Hz, 4H), 2.68 (t, J = 7 Hz, 4H), 1.69 (quint, J = 7 Hz, 4H), 1.43-1.31 (m, 12H), 0.92 (t, J = 7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 144.0, 143.2, 136.4, 133.9, 131.4, 129.0, 128.8, 128.6, 126.8, 126.1, 126.0, 124.6, 124.1, 117.2, 35.8, 31.8, 31.4, 29.0, 22.6, 14.1; HRMS (ESI-MS) m/z calcd for C46H44S2 [M+H]+: 661.2957, found: 661.2937。
化合物2o:
1H NMR (500 MHz, CDCl3) δ 8.71-8.67 (m, 2H), 8.35-8.34 (m, 1H), 8.13-8.10 (m, 1H), 8.00 (s, 1H), 7.71 (d, J = 9 Hz, 2H), 7.68-7.58 (m, 4H), 6.82 (d, J= 8 Hz, 2H), 3.04 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 150.3, 144.4, 136.1, 134.6, 129.1, 128.7, 128.3, 128.2, 127.14, 127.10, 125.8, 125.7, 124.2, 124.0, 123.5, 123.4, 122.5, 116.1, 112.4, 115.6, 40.4; HRMS (MALDI-TOF-MS) m/z calcd for C24H19NS [M]+: 353.1233, found: 353.1208。
化合物2p:
1H NMR (500 MHz, CDCl3) δ 8.69 (t, J = 9 Hz, 2H), 8.34 (d, J= 7 Hz, 1H), 8.10 (d, J = 7 Hz, 1H), 8.00 (s, 1H), 7.67-7.58 (m, 6H), 6.77 (d, J = 9 Hz, 2 H), 3.83 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 146.6, 144.1, 136.1, 134.9, 129.1, 128.7, 128.3, 128.3, 127.47, 127.46, 127.19, 127.0, 125.9, 124.9, 124.2, 124.0, 123.6, 123.5, 116.7, 115.3; HRMS (MALDI-TOF-MS) m/zcalcd for C22H15NS [M]+: 325.0920, found: 325.09051。
化合物2q:
1H NMR (500 MHz, CDCl3) δ 8.72 (d, J= 8 Hz, 3H), 8.41(d, J= 8 Hz,, 3H), 8.03 (s, 3H), 7.71 (t, J = 7 Hz, 3H), 7.56 (d, J = 8 Hz, 6H), 7.40 (t, J = 8 Hz, 3H), 7.19 (d, J = 8 Hz, 6H), 2.62 (t, J = 8 Hz, 6H), 1.62 (quint, J = 8 Hz, 6H), 1.38 (sext, J = 7 Hz, 6H), 0.94 (t, J = 7 Hz, 9H); 13C NMR (125 MHz, CDCl3) δ 143.6,143.0, 137.0, 136.3, 132.0, 131.4, 128.9, 128.7, 128.0, 127.6, 126.6, 126.2, 125.2, 123.9, 123.1, 116.5, 35.3, 33.5, 22.3, 14.0; HRMS (ESI-MS) m/z calcd for C66H54S3 [M+H]+: 943.3460, found: 943.3445。
化合物2r:
1H NMR (500 MHz, CDCl3) δ 8.73 (s, 5H), 7.85 (d, J = 2 Hz, 10H), 7.55 (d, J = 2 Hz, 5H), 1.49 (s, 90H); 13C NMR (125 MHz, CDCl3) δ 151.8, 146.2, 136.7, 135.5, 133.6, 131.8, 122.9, 122.6, 121.3, 120.2, 35.1, 31.4. HRMS (MALDI-TOF-MS) m/zcalcd for C100H110S5 [M]+: 1470.721, found: 1470.720。
化合物2s:
1H NMR (500 MHz, CDCl3) δ 8.19 (d, J= 9 Hz, 1H), 8.11-8.02 (m, 5H), 7.95-7.93 (m, 2H), 7.71-7.57 (m, 10H), 7.44 (s, 1H), 7.33-7.31 (m, 2H), 7.22-7.21 (m, 2H), 7.04 (d, J = 8 Hz, 2H), 2.35 (t, J = 8 Hz, 2H) , 1.57-1.52 (m, 2H), 1.31 (quint, J = 7 Hz, 2H), 0.89 (t, J = 7 Hz, 2H)。
化合物2t:
1H NMR (500 MHz, CDCl3) δ 9.38 (m, 1H), 8.55 (s, 1H), 8.47 (s, 2H), 7.90-7.84 (m, 4H), 7.69(9)-7.69(6)(m, 4H), 7.48 (s, 2H), 1.45 (s, 36H)。
In addition, the spectrum data of each obtained compound are as follows.
Compound 2b:
1 H NMR (500 MHz, CDCl 3 ) δ 8.36 (d, J = 9 Hz, 1H), 8.16 (s, 1H), 7.94 (d, J = 8 Hz, 1H), 7.84 (d, J = 8 Hz , 1H), 7.73-7.69 (m, 3H), 7.62 (t, J = 8 Hz, 1H), 7.53 (t, J = 8 Hz, 1H), 7.27 (d, J = 8 Hz, 2H), 2.42 (s, 3H); 13 C NMR (125 MHz, CDCl 3 ) δ 144.2, 138.1, 136.9, 136.8, 131.7, 131.1, 129.7, 129.2, 128.6, 126.4, 126.2, 125.2, 124.8, 123.5, 120.5, 117.1, 21.2 HRMS (DART-MS) m / zcalcd for C 15 H 15 S [M + H] + : 275.0889, found: 275.0911.
Compound 2c:
1 H NMR (500 MHz, CDCl 3 ) δ 8.12 (d, J = 8 Hz, 1H), 7.91 (d, J = 8 Hz, 1H), 7.78 (d, J = 9 Hz, 1H), 7.72 (d , J = 9 Hz, 1H), 7.67 (d, J = 8 Hz, 2H), 7.62 (s, 1H), 7.57 (t, J = 8 Hz, 1H), 7.50 (t, J = 8 Hz, 1H ), 2.41 (s, 3H); 13 C NMR (125 MHz, CDCl 3 ) δ 137.6, 135.0, 134.6, 133.7, 132.9, 129.4, 129.0, 128.2, 127.9, 127.8, 127.7, 126.5, 126.4, 126.3, 125.8, 123.5, 21.3; HRMS (ESI-MS) m / z calcd for C 15 H 15 S [M + H] + : 275.0889, found: 275.0882.
Compound 2d:
1 H NMR (500 MHz, CDCl 3 ) δ 8.01 (s, 1H), 7.73 (t, J = 9 Hz, 2H), 7.51 (d, J = 8 Hz, 2H), 7.44 (t, J = 7 Hz , 1H), 7.35 (t, J = 7 Hz, 1H), 7.17 (d, J = 8 Hz, 2 H), 7.13 (s, 1H), 4.02 (s, 3H), 2.63 (t, J = 8 Hz, 2H), 1.62 (quint, J = 7 Hz, 2H), 1.37 (sext, J = 7 Hz, 2H), 0.94 (t, J = 7 Hz, 3H); 13 C NMR (125 MHz, CDCl 3 ) δ 153.2, 143.1, 143.0, 138.0, 132.4, 132.2, 131.8, 129.0, 127.6, 126.2, 125.8, 124.8, 124.2, 123.3, 116.8, 55.4, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m / z calcd for C 23 H 22 OS [M + H] + : 347.1464, found: 347.1458.
Compound 2e:
1 H NMR (500 MHz, CDCl 3 ) δ 8.03 (d, J = 8 Hz, 1H), 7.90 (s, 1H), 7.79 (d, J = 8 Hz, 1H), 7.75 (s, 1H), 7.68 (d, J = 9 Hz, 2H), 7.55 (t, J = 8 Hz, 1H), 7.48 (t, J = 8 Hz, 1H), 7.25 (d, J = 9 Hz, 2H), 2.66 (t , J = 8 Hz, 2H), 1.64 (quint, J = 7 Hz, 2H), 1.39 (sext, J = 7 Hz, 2H), 0.95 (t, J = 7 Hz, 3H); 13 C NMR (125 MHz, CDCl 3 ) δ 144.0, 143.6, 138.0, 137.0, 131.5, 131.3, 129.1, 128.0, 127.9, 127.8, 126.9, 126.3, 126.2, 123.5, 120.5, 115.6, 35.4, 33.5, 22.4, 14.0; HRMS (ESI- MS) m / z calcd for C 22 H 19 BrS [M + H] + : 395.0464, found: 395.0457.
Compound 2f:
1 H NMR (500 MHz, CDCl 3 ) δ 8.45 (s, 1H), 8.34 (d, J = 9 Hz, 1H), 8.23 (d, J = 1 Hz, 1H), 8.20 (d, J = 9 Hz , 1H), 8.19 (s, 1H), 8.04 (d, J = 9 Hz, 1H), 7.96 (d, J = 9 Hz, 1H), 7.89 (s, 1H), 7.77 (d, J = 8 Hz , 2H), 7.30 (d, J = 8 Hz, 2H), 2.44 (s, 3H), 1.60 (s, 9H); 13 C NMR (125 MHz, CDCl 3 ) δ 148.8, 144.3, 138.8, 138.4, 134.9 , 131.6, 131.0, 130.8, 129.7, 129.1, 128.2, 127.8, 126.9, 126.6, 125.3, 123.4, 122.5, 122.4, 122.1, 119.7, 119.3, 35.2, 31.9, 21.3; HRMS (ESI-MS) m / z calcd for C 29 H 24 S [M + H] + : 405.1671, found: 405.1666.
Compound 2g:
1 H NMR (500 MHz, CDCl 3 ) δ 8.30 (s, 1H), 8.22 (d, J = 8 Hz, 1H), 8.18 (s, 1H), 7.97 (d, J = 7.0 Hz, 1H), 7.95 -7.92 (m, 2H), 7.75-7.72 (m, 3H), 7.40-7.38 (m, 2H), 7.29 (d, J = 8 Hz, 2H), 2.68 (t, J = 8 Hz, 2H), 1.67 (quint, J = 7 Hz, 2H), 1.41 (sext, J = 7 Hz, 2H), 0.97 (t, J = 7 Hz, 3H); 13 C NMR (125 MHz, CDCl 3 ) δ 145.6, 143.4 , 140.1, 139.2, 138.9, 137.02, 136.98, 133.7, 131.7, 131.0, 129.1, 128.0, 127.5, 127.4, 126.2, 126.0, 122.6, 121.5, 121.3, 119.0, 117.2, 115.3, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m / z calcd for C 28 H 22 S [M + H] + : 391.1515, found: 391.1507.
Compound 2h:
1 H NMR (500 MHz, CDCl 3 ) δ 8.61 (d, J = 8 Hz, 1H), 8.40 (d, J = 7 Hz, 1H), 8.30 (s, 1H), 8.18 (d, J = 7 Hz , 1H), 8.15 (d, J = 8 Hz, 1H), 8.10-8.00 (m, 4H), 7.80 (d, J = 8 Hz, 2H), 7.32 (d, J = 8 Hz, 2H), 2.70 (t, J = 8 Hz, 2H), 1.68 (quint, J = 7 Hz, 2H), 1.43 (sext, J = 7 Hz, 2H), 0.98 (t, J = 7 Hz, 3H); 13 C NMR (125 MHz, CDCl 3 ) δ 143.9, 143.1, 136.3, 135.9, 131.7, 131.7, 129.1, 127.7, 127.3, 126.14, 126.08, 125.9, 125.0, 124.8, 123.4, 122.9, 121.0, 120.5, 118.4, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m / z calcd for C 28 H 22 S [M + H] + : 391.1515, found: 391.1508.
Compound 2i:
1 H NMR (500 MHz, CDCl 3 ) δ 8.20 (s, 1H), 8.07 (d, J = 9 Hz, 1H), 7.95 (d, J = 9 Hz, 1H), 7.88 (d, J = 9 Hz , 1H), 7.86 (d, J = 9 Hz, 1H), 7,82-7.76 (m, 6H), 7.52 (d, J = 9 Hz, 1H), 1.40 (s, 9H); 13 C NMR ( 125 MHz, CDCl 3 ) δ 151.5,144.6, 138.6, 136.5, 136.0, 135.55, 135.48, 134.4, 133.6, 131.5, 130.8, 129.9, 129.6, 127.8, 127.7, 127.5, 127.1, 127.0, 126.71, 126.68, 126.03, 125.98 , 124.8, 124.5, 118.2, 34.7, 31.3; HRMS (ESI-MS) m / zcalcd for C 32 H 22 S [M + H] + : 439.1515, found: 439.1508.
Compound 2j:
1 H NMR (500 MHz, CDCl 3 ) δ 8.01 (d, J = 9 Hz, 2H), 7.87 (d, J = 9 Hz, 2H), 7.70 (d, J = 8 Hz, 4H), 7.65 (s , 2H), 7.27 (d, J = 8 Hz, 4H), 2.67 (t, J = 8 Hz, 2H), 1.66 (quint, J = 7 Hz, 2H), 1.41 (sext, J = 7 Hz, 2H ), 0.97 (t, J = 7 Hz, 3H); 13 C NMR (125 MHz, C 2 D 2 Cl 4 ) δ 143.5, 143.3, 138.1, 137.5, 131.3, 129.0, 126.1, 125.5, 122.6, 121.2, 120.1 , 35.3, 33.4, 22.6, 14.0; HRMS (ESI-MS) m / zcalcd for C 34 H 32 S 2 [M + H] + : 505.2018, found: 505.2010.
Compound 2k:
1 H NMR (500 MHz, CDCl 3 ) δ 8.38 (dd, J = 6, 3 Hz, 2H), 8.14 (s, 2H), 7.72 (d, J = 8 Hz, 4H), 7.63 (dd, J = 6, 3 Hz, 2H), 7.28 (d, J = 8 Hz, 4H), 2.68 (t, J = 8 Hz, 4H), 1.67 (quint, J = 7 Hz, 4H), 1.42 (sext, J = 7 Hz, 4H), 0.97 (t, J = 7 Hz, 6H); 13 C NMR (125 MHz, CDCl 3 ) δ 143.0, 142.2, 135.0, 131.6, 131.0, 129.0, 127.5, 126.0, 125.6, 124.3, 117.6 , 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m / zcalcd for C 34 H 32 S 2 [M + H] + : 505.2018, found: 505.2008.
Compound 2l:
1 H NMR (500 MHz, CDCl 3 ) δ 8.33 (d, J = 8 Hz, 1H), 8.12 (d, J = 8 Hz, 1H), 8.11 (s, 1H), 7.72 (s, 1H), 7.71 (d, J = 7 Hz, 4H), 7.58-7.40 (m, 2H), 7.26 (d, J = 7 Hz, 4H), 2.67 (t, J = 8 Hz, 4H), 1.66 (quint, J = 7 Hz, 4H), 1.41 (sext, J = 7 Hz, 4H), 0.97 (t, J = 7 Hz, 6H); 13 C NMR (125 MHz, CDCl 3 ) δ 144.8, 143.4, 143.0, 142.5, 135.4 , 133.9, 132.9, 132.2, 131.8, 131.5, 129.1, 127.3, 127.1, 126.2, 126.1, 125.94, 125.89, 124.58, 124.2, 117.7, 117.5, 35.4, 33.5, 22.4, 14.0; HRMS (ESI-MS) m / z calcd for C 34 H 32 S 2 [M + H] + : 505.2018, found: 505.2010.
Compound 2m:
1 H NMR (500 MHz, CDCl 3 , 25 ° C) δ 7.9 (s, 4H), 7.81 (d, J = 8.0 Hz, 4H), 7.78 (s, 2H), 7.30 (d, J = 8.0 Hz, 4H ), 2.68 (t, J = 7.8 Hz, 2H), 1.70-1.64 (m, 4H), 1.40-1.31 (m, 12H), 0.92-0.89 (m, 6H); 13 C NMR (125 MHz, CDCl 3 , 25 ° C) δ 145.2, 143.4, 140.8, 139.0, 133.5, 131.7, 129.1, 129.0, 126.5, 126.1, 124.3, 121.4, 119.8, 35.8, 31.7, 31.4, 29.0, 22.6, 14.1; HRMS (ESI-MS) m / z calcd for C 38 H 40 S 2 [M + H] + : 561.2644, found: 561.2632.
Compound 2n:
1 H NMR (500 MHz, CDCl 3 ) δ 9.36 (dd, J = 8, 2 Hz, 2H), 8.50 (dd, J = 8, 2 Hz, 2H), 8.22 (s, 2H), 7.79 (d, J = 8 Hz, 4H), 7.79-7.75 (m, 4H), 7.29 (d, J = 8 Hz, 4H), 2.68 (t, J = 7 Hz, 4H), 1.69 (quint, J = 7 Hz, 4H), 1.43-1.31 (m, 12H), 0.92 (t, J = 7 Hz, 6H); 13 C NMR (125 MHz, CDCl 3 ) δ 144.0, 143.2, 136.4, 133.9, 131.4, 129.0, 128.8, 128.6 , 126.8, 126.1, 126.0, 124.6, 124.1, 117.2, 35.8, 31.8, 31.4, 29.0, 22.6, 14.1; HRMS (ESI-MS) m / z calcd for C 46 H 44 S 2 [M + H] + : 661.2957 , found: 661.2937.
Compound 2o:
1 H NMR (500 MHz, CDCl 3 ) δ 8.71-8.67 (m, 2H), 8.35-8.34 (m, 1H), 8.13-8.10 (m, 1H), 8.00 (s, 1H), 7.71 (d, J = 9 Hz, 2H), 7.68-7.58 (m, 4H), 6.82 (d, J = 8 Hz, 2H), 3.04 (s, 6H); 13 C NMR (125 MHz, CDCl 3 ) δ 150.3, 144.4, 136.1, 134.6, 129.1, 128.7, 128.3, 128.2, 127.14, 127.10, 125.8, 125.7, 124.2, 124.0, 123.5, 123.4, 122.5, 116.1, 112.4, 115.6, 40.4; HRMS (MALDI-TOF-MS) m / z calcd for C 24 H 19 NS [M] + : 353.1233, found: 353.1208.
Compound 2p:
1 H NMR (500 MHz, CDCl 3 ) δ 8.69 (t, J = 9 Hz, 2H), 8.34 (d, J = 7 Hz, 1H), 8.10 (d, J = 7 Hz, 1H), 8.00 (s , 1H), 7.67-7.58 (m, 6H), 6.77 (d, J = 9 Hz, 2 H), 3.83 (s, 2H); 13 C NMR (125 MHz, CDCl 3 ) δ 146.6, 144.1, 136.1, 134.9, 129.1, 128.7, 128.3, 128.3, 127.47, 127.46, 127.19, 127.0, 125.9, 124.9, 124.2, 124.0, 123.6, 123.5, 116.7, 115.3; HRMS (MALDI-TOF-MS) m / zcalcd for C 22 H 15 NS [M] + : 325.0920, found: 325.09051.
Compound 2q:
1 H NMR (500 MHz, CDCl 3 ) δ 8.72 (d, J = 8 Hz, 3H), 8.41 (d, J = 8 Hz ,, 3H), 8.03 (s, 3H), 7.71 (t, J = 7 Hz, 3H), 7.56 (d, J = 8 Hz, 6H), 7.40 (t, J = 8 Hz, 3H), 7.19 (d, J = 8 Hz, 6H), 2.62 (t, J = 8 Hz, 6H), 1.62 (quint, J = 8 Hz, 6H), 1.38 (sext, J = 7 Hz, 6H), 0.94 (t, J = 7 Hz, 9H); 13 C NMR (125 MHz, CDCl 3 ) δ 143.6, 143.0, 137.0, 136.3, 132.0, 131.4, 128.9, 128.7, 128.0, 127.6, 126.6, 126.2, 125.2, 123.9, 123.1, 116.5, 35.3, 33.5, 22.3, 14.0; HRMS (ESI-MS) m / z calcd for C 66 H 54 S 3 [M + H] + : 943.3460, found: 943.3445.
Compound 2r:
1 H NMR (500 MHz, CDCl 3 ) δ 8.73 (s, 5H), 7.85 (d, J = 2 Hz, 10H), 7.55 (d, J = 2 Hz, 5H), 1.49 (s, 90H); 13 C NMR (125 MHz, CDCl 3 ) δ 151.8, 146.2, 136.7, 135.5, 133.6, 131.8, 122.9, 122.6, 121.3, 120.2, 35.1, 31.4.HRMS (MALDI-TOF-MS) m / zcalcd for C 100 H 110 S 5 [M] + : 1470.721, found: 1470.720.
Compound 2s:
1 H NMR (500 MHz, CDCl 3 ) δ 8.19 (d, J = 9 Hz, 1H), 8.11-8.02 (m, 5H), 7.95-7.93 (m, 2H), 7.71-7.57 (m, 10H), 7.44 (s, 1H), 7.33-7.31 (m, 2H), 7.22-7.21 (m, 2H), 7.04 (d, J = 8 Hz, 2H), 2.35 (t, J = 8 Hz, 2H), 1.57 -1.52 (m, 2H), 1.31 (quint, J = 7 Hz, 2H), 0.89 (t, J = 7 Hz, 2H).
Compound 2t:
1 H NMR (500 MHz, CDCl 3 ) δ 9.38 (m, 1H), 8.55 (s, 1H), 8.47 (s, 2H), 7.90-7.84 (m, 4H), 7.69 (9) -7.69 (6) (m, 4H), 7.48 (s, 2H), 1.45 (s, 36H).

[実施例2:チオフェン環縮合芳香族化合物のワンポット合成(薗頭カップリング−チオフェン環縮環)]   [Example 2: One-pot synthesis of thiophene ring condensed aromatic compound (Sonogashira coupling-thiophene ring condensed ring)]

Figure 2017218381
Figure 2017218381

[式中、Tfはトリフルオロメタンスルホニル基を示す。dppfは1,1’−ビス(ジフェニルホスフィノ)フェロセンを示す。Etはエチル基を示す。以下同様である。]
外気中で、フェナントレン−9−イルトリフルオロメタンスルホネート(163 mg, 0.5 mmol, 1.0当量)、酢酸パラジウム(Pd(OAc)2; 2.2 mg, 0.01 mmol, 2 mol%)、1,1’−ビス(ジフェニルホスフィノ)フェロセン(dppf; 5.5 mg, 0.01 mmol, 2 mol%)、及びCuI(1.9 mg, 0.01 mmol, 2 mol%)をシュレンクチューブに投入した。通常のシュレンク技法(evacuate-refill cycle)を用いて、チューブをアルゴンで充填した。チューブにジメチルホルムアミド(DMF; 5.0 mL)、トリエチルアミン(Et3N; 2当量)、及び1−(tert−ブチル)−4−エチニルベンゼン(79 mg, 0.5 mmol, 1.0当量)を入れ、混合物を70℃で12時間加熱し、次いで、アルゴン雰囲気下に3当量の硫黄(S8)を反応混合物に添加し、磁気撹拌子で攪拌しながらさらに140℃で48時間加熱した。次に、混合物を室温まで冷却した。得られた溶液を真空下に濃縮した。さらに、混合物をTLCにより精製し、目的化合物2aを得た(128 mg, 70 %収率)。
[Wherein, Tf represents a trifluoromethanesulfonyl group. dppf represents 1,1′-bis (diphenylphosphino) ferrocene. Et represents an ethyl group. The same applies hereinafter. ]
In the open air, phenanthrene-9-yltrifluoromethanesulfonate (163 mg, 0.5 mmol, 1.0 equivalent), palladium acetate (Pd (OAc) 2 ; 2.2 mg, 0.01 mmol, 2 mol%), 1,1′-bis ( Diphenylphosphino) ferrocene (dppf; 5.5 mg, 0.01 mmol, 2 mol%) and CuI (1.9 mg, 0.01 mmol, 2 mol%) were put into a Schlenk tube. The tube was filled with argon using the usual Schlenk technique (evacuate-refill cycle). A tube was charged with dimethylformamide (DMF; 5.0 mL), triethylamine (Et 3 N; 2 eq), and 1- (tert-butyl) -4-ethynylbenzene (79 mg, 0.5 mmol, 1.0 eq). Heated at 12 ° C. for 12 hours, then 3 equivalents of sulfur (S 8 ) was added to the reaction mixture under an argon atmosphere and further heated at 140 ° C. for 48 hours with stirring with a magnetic stir bar. The mixture was then cooled to room temperature. The resulting solution was concentrated under vacuum. Furthermore, the mixture was purified by TLC to obtain the target compound 2a (128 mg, 70% yield).

[実施例3:ジアリールジインのチオフェン環縮環反応]
実施例3−1:化合物2uの合成
[Example 3: Thiophene ring condensation reaction of diaryldiyne]
Example 3-1: Synthesis of compound 2u

Figure 2017218381
Figure 2017218381

外気中で、化合物1u(35.6 mg, 0.1 mmol, 1.0当量)、及び硫黄(S8; 102 mg, 0.4 mmol, 4.0当量)をシュレンクチューブに投入した。通常のシュレンク技法(evacuate-refill cycle)を用いて、チューブをアルゴンで充填した。チューブに乾燥ジメチルホルムアミド(DMF; 1.0 mL)を入れ、混合物を140℃で48時間加熱した。次に、混合物を室温まで冷却した。得られた溶液を真空下に濃縮した。さらに、GPCにより精製し、目的化合物2uを得た(15.3 mg, 36 %収率)。
1H NMR (500 MHz, CDCl3) δ 8.78 (d, J= 8 Hz, 1H), 8.73-8.71 (m, 1H), 8.46 (d, J = 8 Hz, 1H), 8.14-8.12 (m, 1H), 7.81 (t, J = 7 Hz, 1H), 7.72 (t, J = 7 Hz, 1H), 7,68 (d, J = 8 Hz, 2H), 7.67-7.63 (m, 1H), 7.26 (d, J = 8 Hz, 1H), 2.68 (t, J = 8 Hz, 2H), 1.67 (quint, J = 7 Hz, 2H), 1.42 (sext, J = 7 Hz, 2H), 0.97 (t, J = 7 Hz, 3H); 13C NMR (125 MHz, C2D2Cl4) δ 150.5, 146.4, 141.8, 141.1, 136.9, 134.7, 132.3, 132.2, 131.8, 131.5, 131.0, 130.7, 130.6, 130.2, 129.7, 129.4, 128.9, 127.7, 127.0, 126.8, 126.7, 118.4, 38.5, 36.6, 25.7, 17.2. HRMS (MALDI-TOF-MS) m/z calcd for C28H22S2 [M]+: 422.1157, found: 422.1148。
In the open air, compound 1u (35.6 mg, 0.1 mmol, 1.0 equivalent) and sulfur (S 8 ; 102 mg, 0.4 mmol, 4.0 equivalent) were added to a Schlenk tube. The tube was filled with argon using the usual Schlenk technique (evacuate-refill cycle). The tube was charged with dry dimethylformamide (DMF; 1.0 mL) and the mixture was heated at 140 ° C. for 48 hours. The mixture was then cooled to room temperature. The resulting solution was concentrated under vacuum. Further, purification by GPC gave the target compound 2u (15.3 mg, 36% yield).
1 H NMR (500 MHz, CDCl 3 ) δ 8.78 (d, J = 8 Hz, 1H), 8.73-8.71 (m, 1H), 8.46 (d, J = 8 Hz, 1H), 8.14-8.12 (m, 1H), 7.81 (t, J = 7 Hz, 1H), 7.72 (t, J = 7 Hz, 1H), 7,68 (d, J = 8 Hz, 2H), 7.67-7.63 (m, 1H), 7.26 (d, J = 8 Hz, 1H), 2.68 (t, J = 8 Hz, 2H), 1.67 (quint, J = 7 Hz, 2H), 1.42 (sext, J = 7 Hz, 2H), 0.97 ( t, J = 7 Hz, 3H); 13 C NMR (125 MHz, C 2 D 2 Cl 4 ) δ 150.5, 146.4, 141.8, 141.1, 136.9, 134.7, 132.3, 132.2, 131.8, 131.5, 131.0, 130.7, 130.6 , 130.2, 129.7, 129.4, 128.9, 127.7, 127.0, 126.8, 126.7, 118.4, 38.5, 36.6, 25.7, 17.2.HRMS (MALDI-TOF-MS) m / z calcd for C 28 H 22 S 2 [M] + : 422.1157, found: 422.1148.

実施例3−2:化合物2vの合成Example 3-2: Synthesis of compound 2v

Figure 2017218381
Figure 2017218381

外気中で、化合物1v(149 mg, 0.24 mmol, 1.0当量)、及び硫黄(S8; 122.9 mg, 0.48 mmol, 2当量)をシュレンクチューブに投入した。通常のシュレンク技法(evacuate-refill cycle)を用いて、チューブをアルゴンで充填した。チューブに乾燥ジメチルホルムアミド(DMF; 3.0 mL)及び乾燥エタノール(EtOH; 1.2 mL)を入れ、混合物を140℃で48時間加熱した。次に、混合物を室温まで冷却した。得られた溶液を真空下に濃縮した。さらに、GPCにより精製し、目的化合物2vを得た(46.3 mg, 28 %収率)。
1H NMR (500 MHz, CDCl3) δ 8.27 (s, 2H), 7.55 (s, 2H), 7.53 (d, J= 2 Hz, 4H), 7.44 (t, J = 2 Hz, 2H), 1.40 (s, 36H); 13C NMR (125 MHz, CDCl3) δ 151.7, 148.8, 140.1, 140.0, 133.8, 132.7, 130.4, 122.7, 120.6, 116.3, 115.4, 35.1, 31.5; HRMS (MALDI-TOF-MS) m/z calcd for C42H46S4 [M]+: 614.3035, found: 614.3024. HRMS (MALDI-TOF-MS) m/z calcd for C42H46S4 [M]+: 678.2477, found: 678.2479。
In the open air, Compound 1v (149 mg, 0.24 mmol, 1.0 equivalent) and sulfur (S 8 ; 122.9 mg, 0.48 mmol, 2 equivalent) were added to a Schlenk tube. The tube was filled with argon using the usual Schlenk technique (evacuate-refill cycle). The tube was charged with dry dimethylformamide (DMF; 3.0 mL) and dry ethanol (EtOH; 1.2 mL) and the mixture was heated at 140 ° C. for 48 hours. The mixture was then cooled to room temperature. The resulting solution was concentrated under vacuum. Further, purification by GPC gave the target compound 2v (46.3 mg, 28% yield).
1 H NMR (500 MHz, CDCl 3 ) δ 8.27 (s, 2H), 7.55 (s, 2H), 7.53 (d, J = 2 Hz, 4H), 7.44 (t, J = 2 Hz, 2H), 1.40 (s, 36H); 13 C NMR (125 MHz, CDCl 3 ) δ 151.7, 148.8, 140.1, 140.0, 133.8, 132.7, 130.4, 122.7, 120.6, 116.3, 115.4, 35.1, 31.5; HRMS (MALDI-TOF-MS ) m / z calcd for C 42 H 46 S 4 [M] + : 614.3035, found: 614.3024.HRMS (MALDI-TOF-MS) m / z calcd for C 42 H 46 S 4 [M] + : 678.2477, found : 678.2479.

実施例3−3:化合物2wの合成Example 3-3: Synthesis of compound 2w

Figure 2017218381
Figure 2017218381

外気中で、化合物1w(157.2 mg, 0.3 mmol, 1.0当量)、及び硫黄(S8; 153.6 mg, 0.6 mmol, 2当量)をシュレンクチューブに投入した。通常のシュレンク技法(evacuate-refill cycle)を用いて、チューブをアルゴンで充填した。チューブに乾燥ジメチルホルムアミド(DMF; 3.0 mL)及び乾燥エタノール(EtOH; 1.2 mL)を入れ、混合物を140℃で24時間加熱した。次に、混合物を室温まで冷却した。得られた溶液を真空下に濃縮した。さらに、GPCにより精製し、目的化合物2wを得た(38.4 mg, 22 %収率)。
1H NMR (500 MHz, CDCl3) δ 7.56 (d, J= 8 Hz, 4H), 7.46 (s, 2H), 7.23 (d, J = 8 Hz, 4H), 2.63 (t, J = 7 Hz, 4H), 1.64 (quint, J = 7 Hz, 4H), 1.37-1.26 (m, 20H), 0.88 (t, J = 7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 145.3, 143.1, 141.6, 132.1, 130.1, 129.2, 125.7, 116.1, 35.8, 32.0, 31.5, 29.6, 29.4(2), 29.3(6), 22.8, 14.2。
In the open air, Compound 1w (157.2 mg, 0.3 mmol, 1.0 equivalent) and sulfur (S 8 ; 153.6 mg, 0.6 mmol, 2 equivalent) were added to a Schlenk tube. The tube was filled with argon using the usual Schlenk technique (evacuate-refill cycle). The tube was charged with dry dimethylformamide (DMF; 3.0 mL) and dry ethanol (EtOH; 1.2 mL) and the mixture was heated at 140 ° C. for 24 hours. The mixture was then cooled to room temperature. The resulting solution was concentrated under vacuum. Further, purification by GPC gave the target compound 2w (38.4 mg, 22% yield).
1 H NMR (500 MHz, CDCl 3 ) δ 7.56 (d, J = 8 Hz, 4H), 7.46 (s, 2H), 7.23 (d, J = 8 Hz, 4H), 2.63 (t, J = 7 Hz , 4H), 1.64 (quint, J = 7 Hz, 4H), 1.37-1.26 (m, 20H), 0.88 (t, J = 7 Hz, 6H); 13 C NMR (125 MHz, CDCl 3 ) δ 145.3, 143.1, 141.6, 132.1, 130.1, 129.2, 125.7, 116.1, 35.8, 32.0, 31.5, 29.6, 29.4 (2), 29.3 (6), 22.8, 14.2.

なお、得られた化合物2wと同じ骨格を有する化合物は、μ= 10.2 cm2 V-1 s-1と報告されていることから、本発明の製造方法によれば、世界最高水準の伝導度を有する有機半導体も容易に合成可能であることが理解できる。 In addition, since the compound having the same skeleton as the obtained compound 2w is reported as μ = 10.2 cm 2 V −1 s −1 , according to the production method of the present invention, the world-class conductivity is obtained. It can be understood that the organic semiconductors can be easily synthesized.

[試験例1:光物理特性]
実施例1−1で得た化合物2a、実施例1−2で得た化合物2f、実施例1−2で得た化合物2g、実施例1−2で得た化合物2h、実施例1−2で得た化合物2i、実施例1−2で得た化合物2j、実施例1−2で得た化合物2k、実施例1−2で得た化合物2l、実施例1−2で得た化合物2m、実施例1−2で得た化合物2n、実施例1−2で得た化合物2o、実施例1−2で得た化合物2p、実施例1−2で得た化合物2q、実施例1−2で得た化合物2r、実施例3−1で得た化合物2u、及び実施例3−2で得た化合物2vについて、吸収スペクトル及び蛍光スペクトルを測定した。結果を図1〜16に示す。なお、図1〜16において、実線は吸収スペクトル、破線は蛍光スペクトルを示す。ΦFは絶対蛍光量子収率を示す。
[Test Example 1: Photophysical properties]
Compound 2a obtained in Example 1-1, Compound 2f obtained in Example 1-2, Compound 2g obtained in Example 1-2, Compound 2h obtained in Example 1-2, Example 1-2 Compound 2i obtained, Compound 2j obtained in Example 1-2, Compound 2k obtained in Example 1-2, Compound 2l obtained in Example 1-2, Compound 2m obtained in Example 1-2, Implementation Compound 2n obtained in Example 1-2, Compound 2o obtained in Example 1-2, Compound 2p obtained in Example 1-2, Compound 2q obtained in Example 1-2, Obtained in Example 1-2 With respect to Compound 2r, Compound 2u obtained in Example 3-1, and Compound 2v obtained in Example 3-2, an absorption spectrum and a fluorescence spectrum were measured. The results are shown in FIGS. In addition, in FIGS. 1-16, a continuous line shows an absorption spectrum and a broken line shows a fluorescence spectrum. Φ F indicates the absolute fluorescence quantum yield.

Claims (8)

多環芳香族炭化水素環又は複素芳香環に、1個以上のチオフェン環が縮合したチオフェン環縮合芳香族化合物の製造方法であって、
多環芳香族化合物又は複素環式化合物と、硫黄とを反応させる工程を備え、
前記多環芳香族化合物又は複素環式化合物は、一般式(1):
Figure 2017218381
[式中、R1は置換されていてもよいアリール基を示す。nは1以上の整数を示す。点線と破線で示される結合は単結合又は二重結合を示す。]
で表される構造を1個以上有している、製造方法。
A method for producing a thiophene ring condensed aromatic compound in which one or more thiophene rings are condensed to a polycyclic aromatic hydrocarbon ring or a heteroaromatic ring,
Comprising a step of reacting a polycyclic aromatic compound or heterocyclic compound with sulfur;
The polycyclic aromatic compound or heterocyclic compound has the general formula (1):
Figure 2017218381
[Wherein, R 1 represents an optionally substituted aryl group. n represents an integer of 1 or more. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond. ]
A manufacturing method having one or more structures represented by:
前記多環芳香族化合物又は複素環式化合物が、一般式(3):
Figure 2017218381
[式中、R1及びnは前記に同じである。Arは置換されていてもよい多環芳香族炭化水素環又は置換されていてもよい複素芳香環を示す。R3は−(C≡C)n−R1で表される基を示す。R3が結合しているAr環上の炭素原子と隣接している炭素原子の少なくとも1つの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合している。mは0以上の整数を示す。]
で表される化合物である、請求項1に記載の製造方法。
The polycyclic aromatic compound or heterocyclic compound is represented by the general formula (3):
Figure 2017218381
[Wherein, R 1 and n are the same as defined above. Ar represents a polycyclic aromatic hydrocarbon ring which may be substituted or a heteroaromatic ring which may be substituted. R 3 represents a group represented by — (C≡C) n —R 1 . The group represented by-(C≡C) n -R 1 is not bonded to at least one carbon atom adjacent to the carbon atom on the Ar ring to which R 3 is bonded. Hydrogen atoms are bonded. m represents an integer of 0 or more. ]
The manufacturing method of Claim 1 which is a compound represented by these.
前記Arが、置換基を有していてもよいナフタレン環、置換基を有していてもよいアントラセン環、置換基を有していてもよいフェナントレン環、置換基を有していてもよいテトラセン環、置換基を有していてもよいピレン環、置換基を有していてもよいフルオランテン環、置換基を有していてもよいペンタセン環、置換基を有していてもよいペリレン環、置換基を有していてもよいコラニュレン環、置換基を有していてもよいクリセン環、置換基を有していてもよいベンゾ[c]ナフト[2,1-p]クリセン環、置換基を有していてもよいチオフェン環、置換基を有していてもよいベンゾチオフェン環、若しくは置換基を有していてもよいジチエノベンゼン環、又はこれらの環にベンゼン環を1個以上縮合した環である、請求項2に記載の製造方法。 Ar represents an optionally substituted naphthalene ring, an optionally substituted anthracene ring, an optionally substituted phenanthrene ring, and an optionally substituted tetracene. A ring, an optionally substituted pyrene ring, an optionally substituted fluoranthene ring, an optionally substituted pentacene ring, an optionally substituted perylene ring, Optionally substituted corannulene ring, optionally substituted chrysene ring, optionally substituted benzo [c] naphtho [2,1-p] chrysene ring, substituent A thiophene ring optionally having a substituent, a benzothiophene ring optionally having a substituent, a dithienobenzene ring optionally having a substituent, or one or more of these rings condensed with a benzene ring The production method according to claim 2, wherein the ring is a ring. 前記反応工程が、極性溶媒中で行われる、請求項1〜3のいずれかに記載の製造方法。 The manufacturing method in any one of Claims 1-3 with which the said reaction process is performed in a polar solvent. 前記多環芳香族化合物又は複素環式化合物が、一般式(1A)
Figure 2017218381
[式中、R1は前記に同じである。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有しており、
製造されるチオフェン環縮合芳香族化合物が、一般式(2A):
Figure 2017218381
[式中、R2は、R1と同一の基か、R1が還元された基であり、置換されていてもよいアリール基を示す。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有している、請求項1に記載の製造方法。
The polycyclic aromatic compound or heterocyclic compound has the general formula (1A)
Figure 2017218381
[Wherein, R 1 is the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
Having one or more structures represented by
The produced thiophene ring-fused aromatic compound has the general formula (2A):
Figure 2017218381
Wherein, R 2 is either same group as R 1, a group R 1 is reduced, it represents an aryl group which may be substituted. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
The manufacturing method of Claim 1 which has one or more structures represented by these.
前記多環芳香族化合物又は複素環式化合物が、一般式(1B)
Figure 2017218381
[式中、R1は前記に同じである。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有しており、
製造されるチオフェン環縮合芳香族化合物が、一般式(2B):
Figure 2017218381
[式中、R2は、R1と同一の基か、R1が還元された基であり、置換されていてもよいアリール基を示す。点線と破線で示される結合は多環芳香族炭化水素環又は複素環の一部を構成する単結合又は二重結合を示す。]
で表される構造を1個以上有している、請求項1に記載の製造方法。
The polycyclic aromatic compound or heterocyclic compound has the general formula (1B)
Figure 2017218381
[Wherein, R 1 is the same as defined above. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
Having one or more structures represented by
The produced thiophene ring-fused aromatic compound has the general formula (2B):
Figure 2017218381
Wherein, R 2 is either same group as R 1, a group R 1 is reduced, it represents an aryl group which may be substituted. A bond indicated by a dotted line and a broken line indicates a single bond or a double bond constituting a part of a polycyclic aromatic hydrocarbon ring or a heterocyclic ring. ]
The manufacturing method of Claim 1 which has one or more structures represented by these.
前記多環芳香族化合物又は複素環式化合物が、一般式(3E):
Figure 2017218381
[式中、R1は同一又は異なって、前記に同じである。]
で表される化合物、又は一般式(3F):
Figure 2017218381
[式中、R1は同一又は異なって、前記に同じである。]
で表される化合物である、請求項1〜6のいずれかに記載の製造方法
The polycyclic aromatic compound or the heterocyclic compound is represented by the general formula (3E):
Figure 2017218381
[Wherein, R 1 is the same or different and is the same as defined above. ]
Or a compound represented by the general formula (3F):
Figure 2017218381
[Wherein, R 1 is the same or different and is the same as defined above. ]
The manufacturing method in any one of Claims 1-6 which is a compound represented by these.
置換基を有していてもよい多環芳香族炭化水素環に、1個以上の置換基を有していてもよいチオフェン環が縮合したチオフェン環縮合芳香族化合物であって、
多環芳香族化合物と、硫黄とを反応させてなり、
前記多環芳香族化合物は、
一般式(3):
Figure 2017218381
[式中、R1は置換されていてもよいアリール基を示す。nは1以上の整数を示す。Arは置換されていてもよい多環芳香族炭化水素環又は置換されていてもよい複素芳香環を示す。R3は−(C≡C)n−R1で表される基を示す。R3が結合しているAr環上の炭素原子と隣接している炭素原子の少なくとも1つの炭素原子には前記−(C≡C)n−R1で表される基が結合しておらず水素原子が結合している。mは0以上の整数を示す。]
で表される、チオフェン環縮合芳香族化合物(ただし、ナフタレン環に置換基を有していてもよいチオフェン環が2個縮合した化合物、アントラセン環に置換基を有していてもよいチオフェン環が1個又は4個縮合した化合物、及びアントラキノンに置換基を有していてもよいチオフェン環が1個縮合した化合物を除く)。
A thiophene ring-fused aromatic compound in which a polycyclic aromatic hydrocarbon ring which may have a substituent is condensed with a thiophene ring which may have one or more substituents,
A reaction between a polycyclic aromatic compound and sulfur,
The polycyclic aromatic compound is
General formula (3):
Figure 2017218381
[Wherein, R 1 represents an optionally substituted aryl group. n represents an integer of 1 or more. Ar represents a polycyclic aromatic hydrocarbon ring which may be substituted or a heteroaromatic ring which may be substituted. R 3 represents a group represented by — (C≡C) n —R 1 . The group represented by-(C≡C) n -R 1 is not bonded to at least one carbon atom adjacent to the carbon atom on the Ar ring to which R 3 is bonded. Hydrogen atoms are bonded. m represents an integer of 0 or more. ]
A thiophene ring-condensed aromatic compound represented by (a compound in which two thiophene rings optionally having a substituent are condensed on the naphthalene ring, a thiophene ring optionally having a substituent on the anthracene ring is 1 or 4 condensed compounds, and compounds in which anthraquinone optionally having one substituent thiophene ring is condensed).
JP2016111317A 2016-06-02 2016-06-02 Thiophene ring-condensed aromatic compound and manufacturing method therefor Pending JP2017218381A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016111317A JP2017218381A (en) 2016-06-02 2016-06-02 Thiophene ring-condensed aromatic compound and manufacturing method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016111317A JP2017218381A (en) 2016-06-02 2016-06-02 Thiophene ring-condensed aromatic compound and manufacturing method therefor

Publications (1)

Publication Number Publication Date
JP2017218381A true JP2017218381A (en) 2017-12-14

Family

ID=60658389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016111317A Pending JP2017218381A (en) 2016-06-02 2016-06-02 Thiophene ring-condensed aromatic compound and manufacturing method therefor

Country Status (1)

Country Link
JP (1) JP2017218381A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11322688B2 (en) 2019-05-15 2022-05-03 Samsung Electronics Co., Ltd. N-type semiconductor composition, and thin film, organic photoelectric device, image sensor, and electronic device including the same
US11713952B2 (en) 2019-05-17 2023-08-01 Samsung Electronics Co., Ltd. Organic photoelectric device, image sensor, and electronic device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11322688B2 (en) 2019-05-15 2022-05-03 Samsung Electronics Co., Ltd. N-type semiconductor composition, and thin film, organic photoelectric device, image sensor, and electronic device including the same
US11713952B2 (en) 2019-05-17 2023-08-01 Samsung Electronics Co., Ltd. Organic photoelectric device, image sensor, and electronic device

Similar Documents

Publication Publication Date Title
JP2014517820A (en) Stannyl derivatives of naphthalene diimide and related compositions and methods
CN107021926A (en) A kind of compound containing azepine spiro fluorene and nitrogenous hexa-member heterocycle and its application on OLED
TW201714869A (en) Organic electroluminescent devices and material thereof
JPWO2009096202A1 (en) Halopolycyclic aromatic compound and method for producing the same
CN118955445A (en) A compound and a light-emitting device
CN103421012A (en) Method for preparing tricarbazole material from aryl indolone in one step
KR20180097955A (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
KR102422398B1 (en) Fused polycyclic compound, and preparation method and use thereof
EP3098227B1 (en) Phosphole compound and fluorescent dye containing same
JP2010235575A (en) Method of producing nitrogen-containing condensed heterocyclic compound
JP4908882B2 (en) Organic π-electron material having benzobisazole skeleton and method for producing the same
JP2017218381A (en) Thiophene ring-condensed aromatic compound and manufacturing method therefor
TWI825564B (en) Method for preparing deuterated anthracene compound, reaction composition, deuterated anthracene compound and composition
WO2013183327A1 (en) Method for producing compound having condensed ring structure, compound having condensed ring structure, and organic light-emitting device using same
CN115650916B (en) A method for synthesizing spiro-substituted acridine compounds and their application
JP2012176928A (en) Pyrene derivative, production method of pyrene derivative, complex, catalyst, electronic material, light-emitting material and pigment
Umeda et al. Synthesis and Photophysical Properties of 9, 10-Bis (3-aryl-2-naphthyl) anthracenes
CN103113174B (en) Preparation method of phenolic compounds
KR20170095916A (en) Organic compounds and electronic device comprising organic layer comprising organic compounds
JPWO2016125845A1 (en) Cross coupling method and method for producing organic compound using the cross coupling method
CN113149848B (en) Diphenylamine derivative organic room temperature phosphorescent compound and its preparation method and application
Alam et al. Comparing the impact of trifluoromethyl versus methoxy group on optoelectronic properties of novel 9, 9′-spirobifluorene-based hole transporting materials: Synthesis and computational studies
KR20190043743A (en) Dicyanstyryl benzene derivatives and fluorescent material comprising the same
CN103204797B (en) The arylamine class luminous organic material of dihydro pentacene and preparation method
JP2008255105A (en) Method for producing aromatic carbonyl compound

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20160623